question,reference_answer,base_answer,rag_answer,agentic_rag_answer
"For a cirrhotic patient with bleeding from large high-flow gastric varices, MELD score 20, and a large gastrorenal shunt on CT, how is BRTO rated for this indication?","BRTO is rated as Usually Appropriate for a cirrhotic patient with bleeding from large high-flow gastric varices, MELD score 20, and a large gastrorenal shunt on CT.","For that scenario (large, high‑flow gastric varices with a sizable gastrorenal shunt in a cirrhotic patient, MELD ≈20), BRTO is considered:

- **A strong/first-line indication** for control of gastric variceal bleeding when a gastrorenal shunt is present.
- In guideline terms, typically **Class I–IIa recommendation, Level B evidence** (varies slightly by society), i.e., a well‑supported, appropriate therapy.

So: BRTO is highly favored and guideline‑supported for this exact indication.",BRTO is rated as “Usually Appropriate” for this indication.,"According to the ACR Appropriateness Criteria for Radiologic Management of Gastric Varices, in a cirrhotic patient with bleeding from large high-flow gastric varices, MELD score 20, and a large gastrorenal shunt, balloon-occluded retrograde transvenous obliteration (BRTO) is rated as “Usually Appropriate” for this indication."
"In a cirrhotic patient with bleeding from large high-flow gastric varices, MELD score 20, and a large gastrorenal shunt on CT, which of the listed management options are considered Usually Appropriate?","For this scenario, the procedures that are considered Usually Appropriate are:
- BRTO
- Endoscopic management","For a cirrhotic patient with large, high‑flow gastric varices, MELD 20, and a large gastrorenal shunt, the management options considered **Usually Appropriate** are:

- **BRTO (Balloon-Occluded Retrograde Transvenous Obliteration)** or its variants (e.g., CARTO, PARTO), using the existing **gastrorenal shunt** to obliterate the gastric varices.  

In current guidelines and appropriateness criteria, BRTO (or similar retrograde obliteration techniques) is usually preferred over TIPS in this specific scenario because of the large gastrorenal shunt and the MELD of 20.","For this cirrhotic patient (MELD 20) with bleeding from large high-flow gastric varices and a large gastrorenal shunt, the options considered Usually Appropriate are:

- Balloon-occluded retrograde transvenous obliteration (BRTO)  
- Endoscopic management","For this scenario (corhotic patient, large high-flow gastric varices, MELD 20, large gastrorenal shunt), the ACR Appropriateness Criteria rate the following options as Usually Appropriate:

- BRTO
- Endoscopic management

Partial splenic embolization, surgical management, and TIPS are only rated as May Be Appropriate in this setting."
"For an acute iliofemoral DVT in a pregnant patient with moderate to severe symptoms, which of the listed treatment options are not rated as Usually Appropriate?","For an acute iliofemoral DVT in a pregnant patient with moderate to severe symptoms, the options that are not rated as Usually Appropriate (i.e., they are May Be Appropriate) are:
- CDT/PMT with or without stent placement
- Graded compression stocking therapy
- Surgical thrombectomy with or without stent placement","For an acute iliofemoral DVT in a pregnant patient with moderate to severe symptoms, the options **not** rated as “Usually Appropriate” (i.e., rated as “May Be Appropriate” or “Usually Not Appropriate”) in the ACR Appropriateness Criteria are:

- **Catheter-directed thrombolysis (CDT) alone**  
- **Mechanical thrombectomy alone**  
- **Systemic thrombolysis**  
- **Surgical thrombectomy**  
- **Inferior vena cava (IVC) filter placement as primary therapy**  

The only options typically rated “Usually Appropriate” are anticoagulation (with pregnancy-appropriate agents) and, in selected cases, CDT with or without mechanical thrombectomy in experienced centers; the rest fall outside “Usually Appropriate.”","For an acute iliofemoral DVT in a pregnant patient with moderate to severe symptoms (Variant 7), the only treatment option rated as “Usually Appropriate” is:

- Anticoagulation alone

Therefore, the options that are **not** rated as “Usually Appropriate” are:

- CDT/PMT with or without stent placement (rated “May Be Appropriate”)  
- Graded compression stocking therapy (rated “May Be Appropriate”)  
- Surgical thrombectomy with or without stent placement (rated “May Be Appropriate”)","For Variant 7 (acute iliofemoral DVT in a pregnant patient with moderate to severe symptoms), the only option rated as Usually Appropriate is:

- Anticoagulation alone

The following listed treatment options are **not** rated as Usually Appropriate (they are all rated May Be Appropriate):

- CDT/PMT with or without stent placement
- Graded compression stocking therapy
- Surgical thrombectomy with or without stent placement"
"In a cirrhotic patient with bleeding from large high-flow gastric varices, MELD score 20, and a large gastrorenal shunt on CT, how do BRTO and TIPS compare in terms of appropriateness?","In this scenario, BRTO is rated as Usually Appropriate, whereas TIPS is rated as May Be Appropriate.",,"For this scenario (cirrhosis, large high‑flow gastric varices, MELD 20, large gastrorenal shunt):

- BRTO is rated **“usually appropriate”**.
- TIPS is rated **“may be appropriate”** (i.e., less favored).

So BRTO is generally the more appropriate choice than TIPS in this high‑MELD patient with a large gastrorenal shunt.","For a cirrhotic patient with bleeding from large high-flow gastric varices, MELD 20, and a large gastrorenal shunt, the ACR Appropriateness Criteria rate the options as follows:

- BRTO: Usually Appropriate
- TIPS: May Be Appropriate

So BRTO is considered more appropriate than TIPS in this specific scenario."
"You are considering anticoagulation alone, CDT/PMT with or without stent placement, graded compression stocking therapy, and surgical thrombectomy with or without stent placement. These options are being evaluated for which specific clinical scenario described in the criteria?",These procedures correspond to the scenario of an acute iliofemoral DVT in a pregnant patient with moderate to severe symptoms.,"These options are being evaluated for **patients with acute iliofemoral deep vein thrombosis (DVT)**—specifically those meeting criteria such as:

- **Symptomatic, acute proximal DVT involving the iliac and/or common femoral vein**  
- **Symptom onset typically within 14 days**  
- **Low bleeding risk and reasonable life expectancy**  

In this scenario, anticoagulation alone is compared with catheter-directed thrombolysis (CDT) or pharmacomechanical thrombectomy (PMT) ± stenting, compression stockings, and open surgical thrombectomy ± stenting.","These options are being evaluated for the scenario:

Iliofemoral DVT with persistent moderate symptoms at least 3 months after initial treatment with anticoagulation alone (Variant 6).","Those four options together—anticoagulation alone; CDT/PMT with or without stent placement; graded compression stocking therapy; and surgical thrombectomy with or without stent placement—are being evaluated for this specific scenario:

“Acute iliofemoral DVT in a pregnant patient with moderate to severe symptoms.”"
"For a patient with elevated bilirubin and suspected sclerosing cholangitis who is undergoing an initial therapeutic procedure, how is an endoscopic internal biliary catheter using a removable plastic stent rated for appropriateness?",Endoscopic internal biliary catheter (removable plastic stent) is rated as Usually Appropriate for the initial therapeutic procedure in a patient with elevated bilirubin and suspected sclerosing cholangitis.,An endoscopic internal biliary catheter using a removable plastic stent is rated **“Appropriate” (A)** as an initial therapeutic procedure for a patient with elevated bilirubin and suspected sclerosing cholangitis.,It is rated as “Usually Appropriate” for the initial therapeutic procedure.,"For this scenario (Variant 2 in the Radiologic Management of Biliary Obstruction criteria), an endoscopic internal biliary catheter using a removable plastic stent is rated as **Usually Appropriate** as the initial therapeutic procedure."
"In a patient with elevated bilirubin and suspected sclerosing cholangitis who needs an initial therapeutic intervention, which of the listed treatment options are considered appropriate or potentially appropriate according to their appropriateness ratings?","For the initial therapeutic procedure in a patient with elevated bilirubin and suspected sclerosing cholangitis, the options that are appropriate or potentially appropriate are:
- Endoscopic internal biliary catheter (removable plastic stent): Usually Appropriate
- Percutaneous internal/external biliary catheter: May Be Appropriate
- Medical management only: May Be Appropriate","For a patient with elevated bilirubin and suspected sclerosing cholangitis who needs an initial therapeutic intervention, the options generally rated as **appropriate or potentially appropriate** (depending on specific imaging and clinical details) are:

- **Endoscopic retrograde cholangiopancreatography (ERCP)** with:
  - Balloon dilation of dominant strictures  
  - Possible short-term stent placement in selected cases  

- **Magnetic resonance cholangiopancreatography (MRCP)** (as a noninvasive initial evaluation to define anatomy and guide need for ERCP)

- **Liver transplantation evaluation** in patients with advanced disease, recurrent cholangitis, or decompensated cirrhosis

- **Ursodeoxycholic acid (UDCA)** at standard doses is often considered *potentially appropriate* (symptomatic/biochemical benefit, though no clear survival benefit)

If you provide the specific list of options you’re choosing from, I can mark each one as appropriate, potentially appropriate, or inappropriate.","For a patient with elevated bilirubin and suspected sclerosing cholangitis who needs an initial therapeutic intervention (Variant 2), the options and their appropriateness are:

- Endoscopic internal biliary catheter (removable plastic stent): **Usually Appropriate**  
- Percutaneous internal/external biliary catheter: **May Be Appropriate**  
- Medical management only: **May Be Appropriate**  

The other listed options (surgery, permanent biliary metallic stent, removable biliary covered stent) are not considered appropriate as initial therapy in this scenario.","For a patient with elevated bilirubin and suspected sclerosing cholangitis undergoing an initial therapeutic procedure, the options are rated as follows:

Considered appropriate or potentially appropriate:
- Endoscopic internal biliary catheter (removable plastic stent) – **Usually Appropriate**
- Percutaneous internal/external biliary catheter – **May Be Appropriate**
- Medical management only – **May Be Appropriate**

Not considered appropriate:
- Surgery – **Usually Not Appropriate**
- Permanent biliary metallic stent – **Usually Not Appropriate**
- Removable biliary covered stent – **Usually Not Appropriate**"
"For the initial therapeutic management of a patient with elevated bilirubin and suspected sclerosing cholangitis, which of the available options are rated as not appropriate?","For the initial therapeutic procedure in a patient with elevated bilirubin and suspected sclerosing cholangitis, the options rated as not appropriate are:
- Surgery: Usually Not Appropriate
- Permanent biliary metallic stent: Usually Not Appropriate
- Removable biliary covered stent: Usually Not Appropriate","For initial therapeutic management of a patient with elevated bilirubin and suspected sclerosing cholangitis, the following options are generally rated **not appropriate**:

- **Liver transplantation** (as an initial step; reserved for advanced/end‑stage disease or complications such as recurrent cholangitis or decompensated cirrhosis).  
- **Systemic corticosteroids or other immunosuppressants** (unless there is clear evidence of an overlap syndrome such as autoimmune hepatitis; routine use in primary sclerosing cholangitis is not appropriate).  
- **Empiric long‑term antibiotics** without evidence of acute cholangitis.  
- **Cholecystectomy** solely for PSC without gallbladder pathology.  
- **Immediate surgical biliary reconstruction or bypass** without first attempting endoscopic evaluation/therapy.  
- **Routine placement of permanent biliary stents** in the absence of a dominant stricture or clear obstructive lesion.  

Initial appropriate management typically focuses on: confirming the diagnosis (MRCP/ERCP), relieving obstruction if a dominant stricture is present (endoscopic dilation ± short‑term stenting), and addressing complications (e.g., treating acute cholangitis).","For a patient with elevated bilirubin and suspected sclerosing cholangitis (Variant 2), the options rated as **not appropriate** are:

- **Surgery** – Usually not appropriate  
- **Permanent biliary metallic stent** – Usually not appropriate  
- **Removable biliary covered stent** – Usually not appropriate","For a patient with elevated bilirubin and suspected sclerosing cholangitis who is undergoing an initial therapeutic procedure, the options rated as **not appropriate** are:

- Surgery – **Usually Not Appropriate**
- Permanent biliary metallic stent – **Usually Not Appropriate**
- Removable biliary covered stent – **Usually Not Appropriate**"
"In a patient with an indwelling retrievable inferior vena cava filter placed for venous thromboembolism who is now tolerating or has completed therapeutic anticoagulation, how do venography at the time of retrieval and CT venography prior to retrieval compare in terms of appropriateness?","For an indwelling retrievable inferior vena cava filter in a patient with venous thromboembolism who is now tolerating or has completed therapeutic anticoagulation:
- Venography at time of retrieval procedure is Usually Appropriate.
- CT venography prior to retrieval is Usually Not Appropriate.","For a patient with a retrievable IVC filter who is now on or has completed therapeutic anticoagulation:

- **Venography at the time of retrieval**  
  - Considered **standard and appropriate** for most routine filter removals.  
  - Performed intra‑procedurally to:
    - Confirm IVC patency and filter position.
    - Detect thrombus in or around the filter.
    - Guide immediate decision‑making (proceed vs abort vs modify technique).  
  - Usually sufficient when there are **no clinical or imaging concerns** for significant thrombus burden, filter tilt, penetration, or fracture.

- **CT venography prior to retrieval**  
  - **Not routinely required** for all patients.  
  - More appropriate when there is:
    - Suspicion of significant thrombus (e.g., recurrent symptoms, prior imaging showing clot in filter).
    - Concern for complex retrieval (marked tilt, penetration into adjacent structures, fracture, long dwell time).
    - Prior failed retrieval attempt.
  - Helps plan advanced or complex retrieval techniques and assess extra‑luminal complications that venography alone may miss.

In summary:  
- **Default**: Venography at the time of retrieval is appropriate and usually adequate.  
- **CT venography**: Reserved for **selected, higher‑risk or complex cases**, not as a universal prerequisite.","For this patient (Variant 8 scenario), venography at the time of retrieval is considered appropriate, whereas CT venography prior to retrieval is usually not appropriate.

Specifically:
- Venography at time of retrieval: Usually appropriate.
- CT venography prior to retrieval: Usually not appropriate.

Venography is typically performed during the retrieval procedure to assess for filter-associated thrombus before removal and for caval injury afterward; CT venography is generally reserved only if particular patient factors favor noninvasive imaging beforehand.","For a patient with an indwelling retrievable IVC filter placed for venous thromboembolism who is now tolerating or has completed therapeutic anticoagulation (Variant 8):

- **Venography at the time of retrieval** is rated **Usually Appropriate**.
- **CT venography prior to retrieval** is rated **Usually Not Appropriate**.

So venography at retrieval is considered appropriate, whereas CT venography beforehand is generally not considered appropriate in this setting."
"For a patient with a retrievable IVC filter placed for venous thromboembolism who is now tolerating or has completed therapeutic anticoagulation, which imaging options around filter retrieval avoid CT-related radiation, and how are they rated for appropriateness?","In this scenario, the non-CT (and thus non–CT-radiation) options are:
- Venography at time of retrieval procedure: Usually Appropriate.
- US Duplex lower extremities prior to retrieval: May Be Appropriate (Disagreement).
The CT-based option, CT venography prior to retrieval, is rated as Usually Not Appropriate.",,"For a patient with a retrievable IVC filter placed for venous thromboembolism who is now tolerating or has completed therapeutic anticoagulation (Variant 8):

Imaging options that avoid CT-related radiation and their appropriateness:

- Venography at time of retrieval procedure  
  - Uses fluoroscopy (x‑ray), not CT  
  - Rated: Usually Appropriate  

- Ultrasound (US duplex) of the lower extremities prior to retrieval  
  - No ionizing radiation  
  - Rated: May Be Appropriate (with panel disagreement)  

- MR venography  
  - Specifically mentioned as an option to image the IVC prior to retrieval and avoids ionizing radiation  
  - The document notes it as an available modality but does not assign it a formal appropriateness rating in the Variant 8 table.","For an indwelling retrievable IVC filter placed for venous thromboembolism in a patient who is now tolerating or has completed therapeutic anticoagulation (Variant 8), the non–CT (no CT radiation) imaging options and their ratings are:

1. **Venography at the time of retrieval procedure**  
   - Modality: Catheter-based contrast venography (fluoroscopy; no CT)  
   - Rating: **Usually Appropriate**

2. **Ultrasound duplex of the lower extremities prior to retrieval**  
   - Modality: Ultrasound (no ionizing radiation)  
   - Rating: **May Be Appropriate** (with panel disagreement)

In contrast, **CT venography prior to retrieval** uses CT radiation and is rated **Usually Not Appropriate** in this scenario."
"For a cirrhotic patient with a solitary hepatocellular carcinoma less than 3 cm, how is percutaneous liver ablation rated in terms of appropriateness?",Percutaneous ablation liver is Usually Appropriate for a cirrhotic patient with a solitary hepatocellular cancer less than 3 cm.,"Percutaneous liver ablation is considered **“usually appropriate”** for a cirrhotic patient with a solitary hepatocellular carcinoma (HCC) less than 3 cm (i.e., a highly appropriate/first-line curative option in this setting).",Percutaneous liver ablation is rated as **“Usually Appropriate”** for a cirrhotic patient with a solitary hepatocellular carcinoma less than 3 cm.,"For a cirrhotic patient with a solitary hepatocellular carcinoma less than 3 cm, **percutaneous liver ablation is rated “Usually Appropriate”** as an initial management option."
"In a cirrhotic patient with a solitary hepatocellular carcinoma under 3 cm, which treatment options are considered Usually Appropriate according to these criteria?","For hepatocellular cancer with a solitary tumor less than 3 cm in a cirrhotic patient, the procedures that are Usually Appropriate are:
- Liver transplantation
- Percutaneous ablation liver
- Surgical liver resection","For a cirrhotic patient with a solitary HCC <3 cm, the treatments considered **Usually Appropriate** (per commonly used criteria such as BCLC and major guideline concordant appropriateness criteria) are:

- **Surgical resection** (if liver function and portal hypertension status allow)
- **Local ablation** (radiofrequency ablation [RFA] or microwave ablation [MWA])
- **Liver transplantation** (if within transplant criteria, e.g., Milan criteria)

These three—resection, ablation, and transplantation—are the standard “Usually Appropriate” options for a solitary HCC <3 cm in a cirrhotic liver.","For a cirrhotic patient with a solitary hepatocellular carcinoma under 3 cm, the treatments considered **Usually Appropriate** are:

- Liver transplantation  
- Percutaneous liver ablation  
- Surgical liver resection","For a cirrhotic patient with a solitary hepatocellular carcinoma <3 cm, the treatments rated **Usually Appropriate** are:

- **Liver transplantation**
- **Percutaneous liver ablation**
- **Surgical liver resection**"
"For a patient with a cancer diagnosis who needs central venous access for weekly chemotherapy infusions for more than 2 weeks, which central venous access option is considered Usually Not Appropriate?","For a patient requiring central venous access for weekly chemotherapy infusion for more than 2 weeks, a nontunneled central venous catheter is Usually Not Appropriate.","For weekly chemotherapy infusions lasting more than 2 weeks, a **non-tunneled central venous catheter** is considered **Usually Not Appropriate**.",The nontunneled central venous catheter is considered Usually Not Appropriate for this scenario.,"For a patient with a cancer diagnosis who requires central venous access for weekly chemotherapy infusions for more than 2 weeks, a **nontunneled central venous catheter** is rated **Usually Not Appropriate**."
"In a cirrhotic patient with a solitary hepatocellular carcinoma less than 3 cm, how do liver transplantation and transarterial chemoembolization compare in terms of appropriateness?","For hepatocellular cancer with a solitary tumor less than 3 cm in a cirrhotic patient, liver transplantation is rated as Usually Appropriate, whereas transarterial chemoembolization is rated as May Be Appropriate.","For a cirrhotic patient with a solitary HCC <3 cm:

- **Liver transplantation (LT)**  
  - **Most appropriate definitive therapy** if the patient is otherwise a transplant candidate and within Milan criteria (single lesion ≤5 cm or up to 3 lesions each ≤3 cm).  
  - Treats both the tumor and the underlying cirrhosis, offering the best long‑term survival and lowest recurrence risk.  
  - Often considered first‑line curative option in decompensated cirrhosis or poor hepatic reserve.

- **Transarterial chemoembolization (TACE)**  
  - Not first‑line for a small, solitary lesion in a transplant‑eligible patient.  
  - Used as:
    - **Bridging therapy** while awaiting LT to prevent progression beyond transplant criteria, or  
    - **Palliative therapy** in patients who are not candidates for LT or ablation/resection.  
  - It is not considered curative in this setting and has higher recurrence compared with LT.

So, LT is the preferred and more appropriate definitive treatment; TACE is mainly adjunctive (bridge/downstaging) or palliative when LT (or other curative options like ablation/resection) is not feasible.","For a cirrhotic patient with a solitary HCC <3 cm:

- **Liver transplantation** is rated **“Usually Appropriate”** and is considered a curative option that treats both the tumor and the underlying cirrhosis, offering the best long‑term survival for eligible patients within Milan criteria.

- **Transarterial chemoembolization (TACE)** in this setting is only **“May Be Appropriate”** and is not a first‑line curative therapy for such very early, transplant‑eligible disease. It is more often used in more advanced or unresectable cases, or as a bridge/downstaging tool to transplantation.

So, transplantation is generally more appropriate than TACE for a solitary <3 cm HCC in a cirrhotic patient.","For a cirrhotic patient with a solitary hepatocellular carcinoma less than 3 cm:

- **Liver transplantation** is rated **Usually Appropriate**.
- **Transarterial chemoembolization (TACE)** is rated **May Be Appropriate**.

So transplantation is considered more appropriate than TACE in this scenario."
"A patient with hepatocellular carcinoma is being evaluated for locoregional therapies that avoid systemic treatment. The options under consideration are combination locoregional therapy, external beam radiation therapy, transarterial chemoembolization, transarterial radioembolization, and bland transarterial embolization. Based on these recommendations, what specific clinical scenario (tumor characteristics and liver status) do these procedures correspond to?",These procedures correspond to the scenario of hepatocellular cancer with a solitary tumor less than 3 cm in a cirrhotic patient.,,"These procedures (combination locoregional therapy, external beam radiation therapy, TACE, TARE, and bland TAE) correspond to:

Hepatocellular carcinoma in a cirrhotic liver that is:
- **Multifocal and bilobar**, with **at least one tumor >5 cm**,  
- **Without specifying vascular invasion** (i.e., Variant 3 scenario in the guideline).","These locoregional procedures correspond to **hepatocellular carcinoma in a cirrhotic liver with a solitary tumor less than 3 cm**.

In that specific scenario (solitary HCC <3 cm, cirrhotic):
- Combination locoregional therapy
- External beam radiation therapy
- Transarterial chemoembolization (TACE)
- Transarterial radioembolization (TARE)
- Bland transarterial embolization

are all listed as options (each rated **May Be Appropriate**) when systemic therapy is being avoided."
"For a cirrhotic patient bleeding from small, low-flow gastric varices with moderate ascites, a MELD score of 18, and no gastrorenal shunt on MRI, how is TIPS rated for this indication?","TIPS is Usually Appropriate for a cirrhotic patient bleeding from small, low-flow gastric varices with moderate ascites, a MELD score of 18, and no gastrorenal shunt on MRI.","For that scenario, TIPS is considered **“appropriate” (A)** for secondary prophylaxis/management of gastric variceal bleeding.

Specifically, in guideline/appropriateness criteria tables (e.g., AASLD/SIR-type consensus), a cirrhotic patient with:

- Small, low-flow gastric varices  
- Ongoing or recent bleeding  
- Moderate ascites  
- MELD ≈18  
- No gastrorenal shunt (so BRTO is not an option)

falls into an **appropriate indication for TIPS** rather than “may be appropriate” or “rarely appropriate.”",TIPS is rated as “Usually Appropriate” for this indication.,"In that scenario, **TIPS is rated “Usually Appropriate.”**"
"In a cirrhotic patient with bleeding from small, low-flow gastric varices, moderate ascites, MELD 18, and no gastrorenal shunt on MRI, which management options are considered appropriate (including both Usually Appropriate and May Be Appropriate)? List all such procedures.","For this scenario, the procedures considered appropriate (Usually Appropriate or May Be Appropriate) are:
- Endoscopic management (Usually Appropriate)
- TIPS (Usually Appropriate)
- Partial splenic embolization (May Be Appropriate)
- Surgical management (May Be Appropriate)","For a cirrhotic patient with bleeding from small, low-flow gastric varices, moderate ascites, MELD 18, and **no gastrorenal shunt on MRI**, the management options considered **appropriate** (ACR Appropriateness Criteria: “Usually Appropriate” or “May Be Appropriate”) are:

1. **Transjugular intrahepatic portosystemic shunt (TIPS)**  
   - Usually Appropriate

2. **Endoscopic cyanoacrylate (glue) injection of gastric varices**  
   - Usually Appropriate

3. **Endoscopic band ligation** (if technically feasible for the specific variceal anatomy)  
   - May Be Appropriate

4. **Balloon-occluded retrograde transvenous obliteration (BRTO) or variants (e.g., CARTO, PARTO)**  
   - Only if an alternative collateral route is identified that can be accessed (e.g., via other systemic–portal collaterals); in the absence of a gastrorenal shunt this is generally limited, but in guideline tables it is still listed as:  
   - May Be Appropriate (contingent on suitable anatomy)

5. **Conservative/medical management adjuncts** (used in combination, not as sole definitive therapy for active bleeding):  
   - Nonselective beta-blockers (for secondary prophylaxis) – May Be Appropriate  
   - Repeated endoscopic therapy sessions – May Be Appropriate  

Procedures that rely specifically on a **gastrorenal shunt** (standard BRTO via gastrorenal shunt) are **not** considered appropriate here because no such shunt is present on MRI.","For this specific patient (Variant 3), the procedures considered appropriate are:

Usually Appropriate:
- Endoscopic management  
- TIPS (transjugular intrahepatic portosystemic shunt)

May Be Appropriate:
- Partial splenic embolization  
- Surgical management","For a cirrhotic patient bleeding from small, low-flow gastric varices with moderate ascites, MELD 18, and no gastrorenal shunt on MRI, the following are considered appropriate:

- **Endoscopic management** – Usually Appropriate
- **TIPS** – Usually Appropriate
- **Partial splenic embolization** – May Be Appropriate
- **Surgical management** – May Be Appropriate"
"For a patient with suspected dysfunction of an upper or lower extremity hemodialysis access based on abnormal clinical or hemodynamic indicators, which of the listed management options are NOT considered Usually Appropriate? Include all procedures that are May Be Appropriate or not appropriate.","For suspected dysfunction of an upper or lower extremity hemodialysis access, the procedures that are NOT Usually Appropriate are:
- Continued hemodialysis access use with surveillance (May Be Appropriate)
- Placement of a new tunneled dialysis catheter (May Be Appropriate)
- Surgical consultation (May Be Appropriate)","For a patient with suspected dysfunction of an upper or lower extremity hemodialysis access based on abnormal clinical or hemodynamic indicators, the following imaging/management options are **NOT** considered “Usually Appropriate” (i.e., they are rated **May Be Appropriate** or **Usually Not Appropriate**) in the ACR Appropriateness Criteria:

**May Be Appropriate**  
- **Duplex Doppler ultrasound** of the dialysis access (used to evaluate stenosis, flow, thrombus, etc.)  
- **Noninvasive physiologic testing** (e.g., access flow measurements, pressure measurements) when available and applicable  
- **CT angiography (CTA)** of the extremity access (with contrast)  
- **MR angiography (MRA)** of the extremity access (with or without contrast), depending on renal function and institutional practice

**Usually Not Appropriate**  
- **Noncontrast CT** of the extremity for evaluation of access dysfunction  
- **Plain radiography** of the extremity access (beyond limited use for catheter position or gross hardware issues)  
- **Nuclear medicine perfusion or flow studies** of the extremity access  

Only options explicitly rated “Usually Appropriate” (typically conventional fistulography/angiography with possible endovascular intervention, and in many scenarios duplex ultrasound) are considered first-line; all of the above are not in the “Usually Appropriate” category and thus meet your requested criteria.","For Variant 1 (suspected dysfunction of upper or lower extremity hemodialysis access based on abnormal clinical or hemodynamic indicators), the procedures that are NOT “Usually Appropriate” (i.e., are May Be Appropriate or Usually Not Appropriate) are:

- MRA extremity area of interest without and with IV contrast – Usually Not Appropriate  
- MRA extremity area of interest without IV contrast – Usually Not Appropriate  
- MRV extremity area of interest without and with IV contrast – Usually Not Appropriate  
- MRV extremity area of interest without IV contrast – Usually Not Appropriate  
- CTA extremity area of interest with IV contrast – Usually Not Appropriate  
- CTV extremity area of interest with IV contrast – Usually Not Appropriate  

There are no “May Be Appropriate” options listed for this specific scenario.","For Variant 2 (suspected dysfunction of an upper or lower extremity hemodialysis access based on abnormal clinical or hemodynamic indicators), the options that are NOT rated “Usually Appropriate” (i.e., May Be Appropriate or not appropriate) are:

- Continued hemodialysis access use with surveillance – May Be Appropriate
- Placement of a new tunneled dialysis catheter – May Be Appropriate
- Surgical consultation – May Be Appropriate"
"In a cirrhotic patient bleeding from small, low-flow gastric varices with moderate ascites, MELD 18, and no gastrorenal shunt on MRI, how do BRTO and TIPS compare in terms of appropriateness for management?","In this scenario, BRTO is rated as Usually Not Appropriate, whereas TIPS is rated as Usually Appropriate.","In this scenario, TIPS is generally more appropriate than BRTO.

Reasoning:

- **No gastrorenal shunt:** BRTO requires a sizable spontaneous gastrorenal (or gastrocaval) shunt to access and obliterate the varices. MRI shows none, so BRTO is technically not feasible or would be very difficult and high‑risk. This alone largely rules out BRTO as a practical option.

- **Varix characteristics (small, low-flow):** BRTO is best for large fundal gastric varices with a well‑developed outflow shunt. Small, low‑flow varices without a shunt are not ideal BRTO targets. TIPS, by lowering portal pressure globally, can still be effective even for smaller gastric varices.

- **Ascites and MELD 18:**  
  - TIPS can help control **ascites** and portal hypertension but carries a nontrivial risk of hepatic encephalopathy and liver decompensation, especially as MELD approaches 18–20. At MELD 18, TIPS is not contraindicated but requires careful selection and counseling.  
  - BRTO tends to **worsen ascites and esophageal varices** by increasing portal pressure; in a patient with moderate ascites, that is a disadvantage even if BRTO were technically possible.

- **Overall appropriateness:**  
  - **BRTO:** Not appropriate here due to lack of a gastrorenal shunt and suboptimal varix anatomy; would also worsen ascites.  
  - **TIPS:** More appropriate option for bleeding control and may improve ascites, provided the patient’s liver function, cardiac status, and encephalopathy risk are acceptable after multidisciplinary evaluation.

So, in this patient: **TIPS is the preferred and practically the only viable interventional option; BRTO is not suitable.**","For this specific scenario (Variant 3):

- BRTO: Usually **not appropriate**. The patient has **no gastrorenal shunt**, which makes them ineligible for BRTO, and BRTO is also associated with a substantial risk of **worsening ascites**, which is undesirable in a patient who already has moderate ascites.

- TIPS: Considered **usually appropriate**. Despite an intermediate MELD of 18 (which makes TIPS somewhat less attractive historically), TIPS is appropriate here because:
  - It is effective for controlling bleeding from small, low-flow gastric varices.
  - It can also help **mitigate ascites**, which is a benefit in this patient.

So, in this patient, TIPS is appropriate and BRTO is not.","For this specific scenario (small, low-flow gastric varices, moderate ascites, MELD 18, no gastrorenal shunt):

- **BRTO** is rated **“Usually Not Appropriate.”** The absence of a gastrorenal shunt makes the patient ineligible for BRTO.
- **TIPS** is rated **“Usually Appropriate.”** In addition to treating the gastric variceal bleeding, TIPS is also favored here because it can help mitigate the patient’s moderate ascites.

So, TIPS is considered appropriate and BRTO is considered inappropriate for this indication."
"You are trying to minimize ionizing radiation exposure when evaluating suspected dysfunction of an upper or lower extremity hemodialysis access (abnormal clinical or hemodynamic indicators). Among the listed options, which imaging or evaluation strategy is rated Usually Appropriate and does not inherently rely on fluoroscopic radiation?",US duplex Doppler hemodialysis access area of interest is Usually Appropriate and does not inherently rely on fluoroscopic radiation.,"The strategy rated **Usually Appropriate** that does **not** inherently rely on fluoroscopic ionizing radiation is:

**Duplex Doppler ultrasound of the hemodialysis access.**",US duplex Doppler evaluation of the hemodialysis access (area of interest) is rated Usually Appropriate and does not inherently rely on fluoroscopic radiation.,"For suspected dysfunction of an upper or lower extremity hemodialysis access, when you want to minimize ionizing radiation, the **Usually Appropriate** option that does not inherently rely on fluoroscopic radiation is:

- **Ultrasound (US) duplex Doppler of the hemodialysis access (area of interest).**

This applies to the initial imaging variant in this scenario and uses ultrasound, which does not involve ionizing radiation."
"For a patient with chronic venous thromboembolism such as chronic thromboembolic pulmonary hypertension, how is balloon pulmonary angioplasty rated in terms of appropriateness?","Balloon pulmonary angioplasty is rated as May Be Appropriate for chronic venous thromboembolism (eg, chronic thromboembolic pulmonary hypertension).","Balloon pulmonary angioplasty (BPA) is generally considered:

- **Appropriate** for patients with:
  - Chronic thromboembolic pulmonary hypertension (CTEPH)
  - Inoperable or technically unsuitable disease for pulmonary endarterectomy (PEA), or
  - Persistent/recurrent PH after PEA  
  - With treatable, segmental/subsegmental lesions in accessible pulmonary arteries  
  - Managed in an experienced, high‑volume CTEPH center

- **Not appropriate / rarely appropriate** for:
  - Patients who are good surgical candidates for PEA with predominantly central/proximal disease
  - Patients without pulmonary hypertension or without hemodynamically significant obstruction
  - Centers without specific BPA expertise

Guidelines (e.g., 2022 ESC/ERS PH guidelines) give BPA a **Class I recommendation** (evidence/consensus that it is beneficial) in inoperable CTEPH or persistent PH after PEA, when performed in expert centers.",Balloon pulmonary angioplasty is rated as **“May Be Appropriate”** for patients with chronic venous thromboembolism such as chronic thromboembolic pulmonary hypertension.,"For a patient with chronic venous thromboembolism such as chronic thromboembolic pulmonary hypertension, **balloon pulmonary angioplasty is rated “May Be Appropriate.”**"
"In a patient with chronic venous thromboembolism, including chronic thromboembolic pulmonary hypertension, which interventions are considered appropriate (Usually Appropriate or May Be Appropriate) according to the criteria?","For chronic venous thromboembolism (eg, chronic thromboembolic pulmonary hypertension), the procedures considered appropriate are:
- Anticoagulation (Usually Appropriate)
- Pulmonary thromboendarterectomy (Usually Appropriate)
- Balloon pulmonary angioplasty (May Be Appropriate)
- Permanent IVC filter (May Be Appropriate)
- Retrievable IVC filter (May Be Appropriate)",,"For chronic venous thromboembolism, including chronic thromboembolic pulmonary hypertension (CTEPH), the interventions considered appropriate are:

Usually Appropriate:
- Anticoagulation  
- Pulmonary thromboendarterectomy  

May Be Appropriate:
- Balloon pulmonary angioplasty  
- Permanent inferior vena cava (IVC) filter  
- Retrievable IVC filter","For chronic venous thromboembolism, including chronic thromboembolic pulmonary hypertension (CTEPH), the following are considered appropriate by the criteria:

**Usually Appropriate**
- **Anticoagulation** (typically extended/indefinite in CTEPH)
- **Pulmonary thromboendarterectomy** (for suitable surgical candidates)

**May Be Appropriate**
- **Balloon pulmonary angioplasty** (for select patients with inoperable CTEPH at experienced centers)
- **Permanent IVC filter**
- **Retrievable IVC filter**

Those five interventions are the ones rated as either Usually Appropriate or May Be Appropriate for this indication."
"For initial treatment of a symptomatic osteoporotic vertebral compression fracture with bone marrow edema or an intravertebral cleft, which listed procedures are considered NOT appropriate?","For symptomatic osteoporotic VCF with bone marrow edema or intravertebral cleft (initial treatment), the procedures considered NOT appropriate are:
- Percutaneous ablation spine (Usually Not Appropriate)
- Radiation oncology consultation (Usually Not Appropriate)
- Systemic radionuclide therapy (Usually Not Appropriate)","For an initial, *symptomatic* osteoporotic vertebral compression fracture with bone marrow edema or an intravertebral cleft, the following are generally considered **NOT appropriate** as first-line procedures:

- **Open surgical fixation/fusion** (e.g., instrumented posterior fusion, corpectomy) in the absence of neurologic deficit or gross instability  
- **Decompressive laminectomy alone** without clear neural compression  
- **Disc arthroplasty or motion-preserving implants** at the involved level  
- **Spinal cord stimulation or neuromodulation procedures** for acute fracture pain  
- **Radiofrequency ablation or other ablative procedures** directed at the vertebral body as primary treatment  
- **Facet joint interventions** (medial branch blocks, facet injections, RFA) as primary treatment for the acute fracture itself  

Initial appropriate management is typically conservative therapy (analgesia, bracing, activity modification) and, in selected patients with persistent severe pain and bone marrow edema or an intravertebral cleft, vertebral augmentation (vertebroplasty or kyphoplasty).","For initial treatment of a symptomatic osteoporotic vertebral compression fracture with bone marrow edema or an intravertebral cleft, the following listed procedures are NOT appropriate:

- Radiation therapy (RT)  
- Systemic radionuclide therapy  
- Percutaneous spinal thermal ablation (ablation spine)","For initial treatment of a **symptomatic osteoporotic vertebral compression fracture with bone marrow edema or an intravertebral cleft**, the following listed procedures are considered **NOT appropriate (Usually Not Appropriate)**:

- **Percutaneous ablation of the spine**
- **Radiation oncology consultation**
- **Systemic radionuclide therapy**

For this scenario, only medical management and percutaneous vertebral augmentation are rated Usually Appropriate; surgical consultation is May Be Appropriate."
"For a patient with chronic venous thromboembolism such as chronic thromboembolic pulmonary hypertension, how do a permanent IVC filter and a retrievable IVC filter compare in terms of appropriateness?","In chronic venous thromboembolism (eg, chronic thromboembolic pulmonary hypertension), both a permanent IVC filter and a retrievable IVC filter are rated as May Be Appropriate, so they have the same appropriateness rating.",,"For chronic venous thromboembolism such as CTEPH:

- Both permanent and retrievable IVC filters are rated as “may be appropriate,” not routinely indicated.
- Anticoagulation (usually indefinite) and, when suitable, pulmonary thromboendarterectomy are the primary recommended therapies.
- Permanent filters have historically been used in CTEPH patients undergoing pulmonary thromboendarterectomy as an adjunct to lifelong anticoagulation, but there are no robust data proving benefit.
- In patients who cannot be safely anticoagulated, IVC filter placement (typically permanent, given the long-term risk) can be considered.
- Retrievable filters are not clearly preferred over permanent filters in CTEPH; permanent filters have had more supporting efficacy data in this specific surgical context, which is why they have been historically favored.

In summary, for CTEPH, either permanent or retrievable filters may be appropriate on an individualized basis, with permanent filters historically preferred around thromboendarterectomy, but overall evidence for benefit is limited.","For a patient with chronic venous thromboembolism such as chronic thromboembolic pulmonary hypertension (CTEPH), **permanent IVC filters and retrievable IVC filters have the same appropriateness rating** in the ACR Appropriateness Criteria:

- **Permanent IVC filter – May Be Appropriate**
- **Retrievable IVC filter – May Be Appropriate**

So neither is preferred over the other based purely on appropriateness rating; selection depends on clinical factors (need/duration of protection, bleeding risk, long‑term retrieval plans, etc.)."
"You are trying to minimize radiation exposure when choosing an initial treatment strategy for a symptomatic osteoporotic vertebral compression fracture with bone marrow edema or an intravertebral cleft. Among the listed options, which non-radiation-based management strategies are considered Usually Appropriate?","For symptomatic osteoporotic VCF with bone marrow edema or intravertebral cleft (initial treatment), the non-radiation-based strategies that are Usually Appropriate are:
- Medical management only
- Percutaneous vertebral augmentation","For a symptomatic osteoporotic vertebral compression fracture with bone marrow edema or an intravertebral cleft, the **non–radiation-based management strategies** that are considered **Usually Appropriate** as initial treatment are:

- **Analgesic medications** (e.g., acetaminophen, opioids as needed/appropriate)  
- **Bracing** (spinal orthosis)  
- **Physical therapy / early mobilization**  

These are typically recommended before image-guided vertebral augmentation or other radiation-based procedures when aiming to minimize radiation exposure.","The non–radiation-based management strategies that are **Usually Appropriate** for an initial treatment of a symptomatic osteoporotic vertebral compression fracture with bone marrow edema or an intravertebral cleft are:

- **Medical management only**  
- **Percutaneous vertebral augmentation**","For a symptomatic osteoporotic vertebral compression fracture with bone marrow edema or an intravertebral cleft (initial treatment), the non–radiation-based strategy that is considered **Usually Appropriate** is:

- **Medical management only**

Percutaneous vertebral augmentation is also Usually Appropriate but involves image guidance (fluoroscopy/CT) and therefore radiation. Surgical consultation is only May Be Appropriate, and the other options in this scenario (percutaneous ablation, radiation oncology consultation, systemic radionuclide therapy) are Usually Not Appropriate."
"For a patient 5 weeks after acute pancreatitis with a walled-off pancreatic collection indenting the stomach and affecting the gastric outlet, and with a patent pancreatic duct, how is endoscopic cystgastrostomy rated for appropriateness?",Endoscopic cystgastrostomy is Usually Appropriate.,"Endoscopic cystgastrostomy is generally rated **“Appropriate”** in this scenario.

Rationale (per guideline/consensus criteria):
- Walled-off pancreatic collection
- Symptomatic (gastric outlet obstruction from indentation)
- >4 weeks from acute pancreatitis
- Patent pancreatic duct does not contraindicate drainage

So, this clinical situation meets standard criteria for **appropriate** endoscopic cystgastrostomy.",Endoscopic cystgastrostomy is rated as **“Usually Appropriate.”**,"For this clinical scenario, **endoscopic cystgastrostomy is rated “Usually Appropriate”** as an initial intervention."
"In a patient 5 weeks after acute pancreatitis with a percutaneously accessible walled-off pancreatic collection compressing the gastric outlet and a patent pancreatic duct, which management options are considered appropriate or potentially appropriate?","For this scenario, the following procedures are considered appropriate or potentially appropriate:
- Endoscopic cystgastrostomy: Usually Appropriate
- Percutaneous catheter drainage only: May Be Appropriate
- Percutaneous needle aspiration: May Be Appropriate
- Surgical cystenterostomy: May Be Appropriate","For a 5‑week‑old, percutaneously accessible walled‑off pancreatic collection (WON) causing gastric outlet compression with a patent pancreatic duct, guideline‑supported options include:

**Appropriate / Potentially Appropriate:**
1. **Percutaneous catheter drainage (PCD)**  
   - Especially appropriate since the collection is already percutaneously accessible and is causing symptomatic compression.

2. **Endoscopic ultrasound (EUS)–guided transmural drainage**  
   - Cystogastrostomy or cystoduodenostomy with plastic stents or lumen‑apposing metal stents (LAMS), given the mature wall (≥4 weeks) and symptomatic mass effect.

3. **Step‑up approach**  
   - Initial PCD or endoscopic drainage followed, if needed, by minimally invasive necrosectomy (endoscopic or video‑assisted retroperitoneal debridement).

4. **Conservative management alone**  
   - Only “potentially appropriate” if symptoms are mild and not clearly due to the collection; in this case, with gastric outlet compression, intervention is usually favored.

5. **Surgical drainage / necrosectomy**  
   - Considered when less invasive approaches fail or are not feasible; usually not first‑line but still an appropriate option in selected cases.

**Generally not appropriate as first‑line in this scenario:**
- ERCP with pancreatic duct stenting alone (duct is patent and the main problem is mass effect from the WON).","For this patient, the ACR panel considers the following management options:

- **Endoscopic cystgastrostomy – Usually appropriate**  
- **Percutaneous catheter drainage only – May be appropriate**  
- **Percutaneous needle aspiration – May be appropriate**  
- **Surgical cystenterostomy – May be appropriate**  

Conservative management alone is considered **usually not appropriate** in this scenario.","For a patient 5 weeks after acute pancreatitis with a percutaneously accessible walled‑off pancreatic collection compressing the gastric outlet and a patent pancreatic duct, the ACR Appropriateness Criteria list the following management options as appropriate or potentially appropriate:

- **Endoscopic cystgastrostomy – Usually Appropriate**
- **Percutaneous catheter drainage only – May Be Appropriate**
- **Percutaneous needle aspiration – May Be Appropriate**
- **Surgical cystenterostomy – May Be Appropriate**

**Conservative management only** is **Usually Not Appropriate** in this setting."
"For an otherwise healthy patient with acute iliofemoral DVT and moderate to severe symptoms present for less than 14 days, which of the listed treatment options are NOT considered appropriate (i.e., not ""Usually Appropriate"")?","In this scenario, the following procedure is not rated as ""Usually Appropriate"":
- Surgical thrombectomy techniques: May Be Appropriate","For an otherwise healthy patient with acute iliofemoral DVT and moderate–severe symptoms <14 days, the following options are **NOT** considered “Usually Appropriate” (i.e., they are either “May Be Appropriate” or “Usually Not Appropriate” in most guidelines/appropriate-use criteria):

- **Inferior vena cava (IVC) filter placement alone** (without contraindication to anticoagulation)  
- **Systemic thrombolysis** (full-dose IV tPA)  
- **No anticoagulation / observation alone**  
- **Surgical thrombectomy as routine first-line therapy** (without specific indications such as limb-threatening ischemia or failure of less invasive options)  

In contrast, **therapeutic anticoagulation** (with or without catheter-directed thrombolysis or pharmacomechanical thrombectomy in selected patients) is generally in the “Usually Appropriate” category.","For an otherwise healthy patient with acute iliofemoral DVT and moderate to severe symptoms present for less than 14 days (Variant 2), the options that are NOT “Usually Appropriate” are:

- Surgical thrombectomy techniques (rated “May Be Appropriate,” not “Usually Appropriate”).","For an otherwise healthy patient with acute iliofemoral DVT and moderate to severe symptoms present for less than 14 days (Variant 2), the following treatment options are **not** considered appropriate in the sense of being “Usually Appropriate”:

- **Surgical thrombectomy techniques** – rated **May Be Appropriate**, not Usually Appropriate.

The options that are Actually rated **Usually Appropriate** in this scenario are:
- **Anticoagulation alone**
- **Catheter-directed thrombolysis/percutaneous mechanical thrombectomy (CDT/PMT) with or without stent placement**"
"For an otherwise healthy patient with acute iliofemoral DVT and moderate to severe symptoms for less than 14 days, how do anticoagulation alone and CDT/PMT with or without stent placement compare in terms of appropriateness?","In this scenario, both options are rated the same: 
- Anticoagulation alone: Usually Appropriate
- CDT/PMT with or without stent placement: Usually Appropriate",,"For an otherwise healthy patient with acute iliofemoral DVT and moderate to severe symptoms for less than 14 days:

- **Anticoagulation alone** is **usually appropriate** as first-line therapy.
- **Catheter-directed thrombolysis (CDT) and/or pharmacomechanical thrombectomy (PMT) with or without stent placement** is also **usually appropriate** in this setting.

They are considered complementary rather than mutually exclusive: anticoagulation is standard, and CDT/PMT (often with stenting of obstructive lesions) is added in selected patients—especially younger patients with more proximal iliac/common femoral involvement and low bleeding risk—to improve early symptom relief and reduce severity of post-thrombotic syndrome.","For an otherwise healthy patient with acute iliofemoral DVT and moderate to severe symptoms for less than 14 days, **both** of the following are rated the same:

- **Anticoagulation alone – Usually Appropriate**
- **CDT/PMT with or without stent placement – Usually Appropriate**

They are considered **equally appropriate options** (and may be used complementarily), with choice guided by symptom severity, bleeding risk, and patient factors such as age and preferences."
"You are trying to minimize radiation exposure in a patient 5 weeks after acute pancreatitis with a walled-off pancreatic collection compressing the gastric outlet and a patent pancreatic duct. Among the available options (conservative management only, endoscopic cystgastrostomy, percutaneous catheter drainage only, percutaneous needle aspiration, surgical cystenterostomy), which non-surgical, non-percutaneous option is considered usually appropriate and would avoid percutaneous image-guided radiation exposure?","Endoscopic cystgastrostomy is the non-surgical, non-percutaneous option that is rated as Usually Appropriate and would avoid percutaneous image-guided radiation exposure in this scenario.",Endoscopic cystgastrostomy.,Endoscopic cystgastrostomy.,"The non-surgical, non-percutaneous option that is considered **Usually Appropriate** and avoids percutaneous image‑guided radiation exposure is **endoscopic cystgastrostomy**."
"For a patient with acute iliofemoral DVT, mild symptoms for less than 14 days, and otherwise healthy, how is anticoagulation alone rated for appropriateness?","For acute iliofemoral DVT with mild symptoms less than 14 days in an otherwise healthy patient, anticoagulation alone is rated as Usually Appropriate.","For an otherwise healthy patient with **acute iliofemoral DVT**, **mild symptoms**, and **symptom duration <14 days**, **anticoagulation alone is rated as “Appropriate”** (A) in most appropriateness criteria (e.g., multispecialty guidelines on CDT/thrombolysis).",Anticoagulation alone is rated as **“Usually Appropriate.”**,"For an otherwise healthy patient with acute iliofemoral DVT, mild symptoms, and symptom duration <14 days, **anticoagulation alone is rated “Usually Appropriate.”**"
"In an otherwise healthy patient with acute iliofemoral DVT and mild symptoms for less than 14 days, which procedures are considered appropriate or potentially appropriate treatment options?","For acute iliofemoral DVT with mild symptoms less than 14 days in an otherwise healthy patient, the procedures considered appropriate or potentially appropriate are:
- Anticoagulation alone (Usually Appropriate)
- Graded compression stocking therapy (May Be Appropriate)","For an otherwise healthy patient with **acute iliofemoral DVT**, **mild symptoms**, and **symptom duration <14 days**, the following are considered **appropriate or potentially appropriate** treatment options (in addition to anticoagulation):

- **Catheter-directed thrombolysis (CDT)** – *Potentially appropriate*  
- **Pharmacomechanical catheter-directed thrombolysis (PCDT)** – *Potentially appropriate*  
- **Mechanical thrombectomy (without lytics)** – *Potentially appropriate* in selected cases  

Systemic thrombolysis is generally **not** considered appropriate in this setting.","For an otherwise healthy patient with acute iliofemoral DVT, mild symptoms, and symptom duration <14 days:

- **Usually appropriate:**  
  - Anticoagulation alone  

- **May be appropriate (potentially appropriate):**  
  - Graded compression stocking therapy  

- **Usually not appropriate (thus not considered appropriate options in this scenario):**  
  - Catheter-directed thrombolysis/percutaneous mechanical thrombectomy (CDT/PMT) with or without stent placement  
  - Surgical thrombectomy techniques","For an otherwise healthy patient with acute iliofemoral DVT, mild symptoms, and symptom duration <14 days, the non-anticoagulation procedures are generally **not** considered appropriate or potentially appropriate as primary treatment options. In this scenario:

- **Anticoagulation alone** is rated **Usually Appropriate**.
- **Catheter-directed thrombolysis (CDT)**, **pharmacomechanical thrombectomy (PMT)**, and **venous stent placement** are **not rated as appropriate or potentially appropriate** for routine use when symptoms are only mild, due to the invasive nature and bleeding risk outweighing potential benefit in mildly symptomatic patients.

Thus, **no interventional procedures (CDT, PMT, or stenting)** are considered appropriate or potentially appropriate treatment options in this specific scenario; the appropriate management is anticoagulation alone."
"For a cirrhotic patient bleeding from esophageal and gastric varices not amenable to endoscopic management, with MELD 13, hepatic wedge pressure 22 mmHg, and a small gastrorenal shunt on CT, which of the listed management options are NOT considered appropriate?","In this cirrhotic patient scenario, the procedure that is NOT considered appropriate is:
- BRTO (Usually Not Appropriate)

The other listed options (Partial splenic embolization and Surgical management, both May Be Appropriate, and TIPS, Usually Appropriate) are not in the ""not appropriate"" category.","In this scenario (active variceal bleeding, MELD 13, HVPG 22 mmHg, small gastrorenal shunt), the options that are **not appropriate** are:

1. **Balloon-occluded retrograde transvenous obliteration (BRTO) as definitive therapy**  
   - A *small* gastrorenal shunt makes BRTO technically difficult and less effective.  
   - BRTO also does not decompress portal pressure and is not first-line in this setting when TIPS is feasible.

2. **Conservative medical therapy alone (vasoactive drugs + banding already failed) without a portal decompressive or obliterative procedure**  
   - Ongoing or high-risk bleeding after failed endoscopy requires TIPS or (less commonly) BRTO; medical therapy alone is inadequate.

3. **Surgical shunt or devascularization procedures**  
   - With a MELD of 13 and a feasible interventional radiology option (TIPS), surgery is not appropriate first-line management.

In contrast, **TIPS** (with or without adjunctive embolization of varices) is appropriate and preferred here.","For this Variant 5 scenario (MELD 13, wedge 22 mmHg, small gastrorenal shunt, esophageal and gastric varices not amenable to endoscopy), the ACR table lists:

- TIPS – Usually Appropriate  
- BRTO – Usually Not Appropriate  
- Partial splenic embolization – May Be Appropriate  
- Surgical management – May Be Appropriate  

Therefore, the management option that is NOT considered appropriate is:

- BRTO","In this scenario (cirrhotic patient bleeding from esophageal and gastric varices not amenable to endoscopic management, MELD 13, wedge pressure 22 mmHg, small gastrorenal shunt), the ACR Appropriateness Criteria list the following:

- **TIPS – Usually Appropriate**
- **Partial splenic embolization – May Be Appropriate**
- **Surgical management – May Be Appropriate**
- **BRTO – Usually Not Appropriate**

Therefore, among the listed management options, **balloon‑occluded retrograde transvenous obliteration (BRTO)** is the one **NOT considered appropriate (rated “Usually Not Appropriate”).**"
"In an otherwise healthy patient with acute iliofemoral DVT and mild symptoms for less than 14 days, how does the appropriateness of CDT/PMT with or without stent placement compare with surgical thrombectomy techniques?","For acute iliofemoral DVT with mild symptoms less than 14 days in an otherwise healthy patient, both CDT/PMT with or without stent placement and surgical thrombectomy techniques are rated as Usually Not Appropriate, so neither is preferred based on appropriateness.",,"For an otherwise healthy patient with acute iliofemoral DVT, mild symptoms, and symptom duration <14 days:

- Catheter-directed thrombolysis/percutaneous mechanical thrombectomy (CDT/PMT) with or without stent placement is rated **“Usually Not Appropriate.”**  
- Surgical thrombectomy techniques are also rated **“Usually Not Appropriate.”**

So, in this scenario, both CDT/PMT (± stent) and surgical thrombectomy are similarly inappropriate; the recommended management is anticoagulation alone.","For an otherwise healthy patient with acute iliofemoral DVT, mild symptoms, and symptom duration <14 days, **neither endovascular thrombus-removal procedures (CDT/PMT with or without stent placement) nor open surgical thrombectomy techniques are considered appropriate.**

In the ACR-style appropriateness framework for this clinical scenario:

- **Anticoagulation alone** is rated **“Usually Appropriate.”**
- **Catheter-directed thrombolysis (CDT)/pharmacomechanical thrombectomy (PMT), with or without venous stent placement,** are **not rated as appropriate or potentially appropriate**, because the risk-benefit profile does not favor invasive therapy in patients who are only mildly symptomatic.
- **Surgical thrombectomy techniques** are similarly **not rated as appropriate or potentially appropriate** in this context.

Thus, **CDT/PMT (± stent) and surgical thrombectomy are both considered inappropriate** relative to anticoagulation alone, and one is not favored over the other in terms of appropriateness; both fall outside appropriate or potentially appropriate options for this specific patient profile."
"You are seeing a cirrhotic patient with active bleeding from esophageal and gastric varices that are not amenable to endoscopic management. The MELD score is 13, hepatic wedge pressure is 22 mmHg, and CT shows a small gastrorenal shunt. For this specific clinical situation, which scenario from the ACR data do the following procedures—TIPS, BRTO, partial splenic embolization, and surgical management—correspond to?","These procedures (TIPS, BRTO, partial splenic embolization, and surgical management) correspond to the scenario: ""Cirrhotic patient bleeding from esophageal varices and gastric varices not amenable to endoscopic management with a MELD score of 13 and a hepatic wedge pressure of 22 mmHg. CT demonstrates a small gastrorenal shunt.""","For this specific scenario (cirrhotic patient, active esophageal and gastric variceal bleeding, MELD 13, HVPG 22 mmHg, small gastrorenal shunt, endoscopy not feasible), the ACR Appropriateness Criteria correspond roughly to:

- **TIPS** – Scenario: “Acute variceal bleeding not controlled by endoscopic therapy in a patient with preserved liver function (low MELD) and portal hypertension.”  
  (TIPS is rated usually appropriate as salvage therapy here.)

- **BRTO** – Scenario: “Gastric variceal bleeding with a sizable gastrorenal shunt suitable for retrograde obliteration.”  
  (In your case, only a *small* gastrorenal shunt is present, so this matches the BRTO scenario poorly and is generally less appropriate.)

- **Partial splenic embolization** – Scenario: “Adjunctive therapy for portal hypertension/variceal bleeding in patients who are not ideal TIPS/BRTO candidates, often with hypersplenism.”  
  (Considered a secondary or adjunct option rather than primary therapy for acute uncontrolled bleeding.)

- **Surgical management (e.g., shunt surgery, devascularization)** – Scenario: “Refractory variceal bleeding in patients who are not candidates for or have failed endoscopic and radiologic (TIPS/BRTO) therapy.”  
  (Reserved for select patients with good operative risk when less invasive options are not feasible or have failed.)","For this exact clinical situation (cirrhotic, active bleeding from esophageal and gastric varices not amenable to endoscopy, MELD 13, wedge 22 mmHg, small gastrorenal shunt), the ACR document defines it as **Variant 5**.

Within Variant 5, the procedures correspond as follows:

- **TIPS** → Variant 5: *Usually Appropriate*  
- **BRTO** → Variant 5: *Usually Not Appropriate*  
- **Partial splenic embolization** → Variant 5: *May Be Appropriate*  
- **Surgical management** → Variant 5: *May Be Appropriate*","For a cirrhotic patient with active bleeding from esophageal and gastric varices not amenable to endoscopic management, MELD 13, wedge pressure 22 mmHg, and a small gastrorenal shunt, this matches **Variant 5** in the ACR Appropriateness Criteria for *Radiologic Management of Gastric Varices*.

In **Variant 5**, the procedures correspond as follows:
- **TIPS** – **Usually Appropriate**
- **BRTO** – **Usually Not Appropriate**
- **Partial splenic embolization** – **May Be Appropriate**
- **Surgical management** – **May Be Appropriate**"
"For a cirrhotic patient with hepatocellular carcinoma and vascular invasion, how is transarterial chemoembolization rated for this indication?",Transarterial chemoembolization is rated as May Be Appropriate for hepatocellular cancer that is solitary or multifocal with vascular invasion in a cirrhotic patient.,"For a cirrhotic patient with hepatocellular carcinoma (HCC) and **macrovascular invasion (e.g., portal vein tumor thrombus)**, **transarterial chemoembolization (TACE) is generally *not recommended* and is considered inappropriate or contraindicated** in most guideline systems.

- **BCLC staging**: Vascular invasion = **BCLC C (advanced)** → systemic therapy (e.g., atezolizumab–bevacizumab, durvalumab–tremelimumab, sorafenib, lenvatinib) is recommended, not TACE.  
- **AASLD/EASL**: TACE is indicated for **intermediate-stage (BCLC B) without vascular invasion**; macrovascular invasion is a standard exclusion.  
- **Appropriateness criteria (e.g., SIR/Asia-Pacific)**: TACE in the presence of main portal vein invasion is typically rated **“inappropriate” or “rarely appropriate”**, due to high risk of liver failure and limited benefit.

Some centers may consider **selective/superselective TACE** in segmental or branch portal vein invasion in highly selected patients, but this is an exception and not a guideline-supported standard.",Transarterial chemoembolization (TACE) is rated as **“May Be Appropriate”** for cirrhotic patients with hepatocellular carcinoma and vascular invasion.,"For a cirrhotic patient with hepatocellular carcinoma and vascular invasion (ACR Variant 4: “Solitary or multifocal disease with vascular invasion, cirrhotic”), **transarterial chemoembolization (TACE)** is rated as **“May Be Appropriate.”**"
"In a cirrhotic patient with hepatocellular carcinoma that is solitary or multifocal with vascular invasion, which treatment options are considered appropriate or potentially appropriate according to the criteria?","For hepatocellular cancer that is solitary or multifocal with vascular invasion in a cirrhotic patient, the procedures considered appropriate or potentially appropriate are:
- Systemic therapies (Usually Appropriate)
- Transarterial radioembolization (Usually Appropriate)
- Transarterial chemoembolization (May Be Appropriate)
- Bland transarterial embolization (May Be Appropriate)
- Combination locoregional therapy (May Be Appropriate)
- External beam radiation therapy (May Be Appropriate)","For a cirrhotic patient with HCC that is solitary or multifocal **with vascular invasion**, the treatments considered **appropriate or potentially appropriate** (depending on specific criteria such as liver function, performance status, and extent of invasion) are:

- **Liver transplantation** (in very selected cases, usually if within expanded criteria and after downstaging)  
- **Hepatic resection** (if liver function is preserved and portal hypertension is absent or minimal)  
- **Transarterial chemoembolization (TACE)** (select cases with segmental/branch portal vein invasion and preserved liver function)  
- **Transarterial radioembolization (TARE / Y-90)**  
- **External beam radiation therapy (EBRT), including stereotactic body radiation therapy (SBRT)**  
- **Systemic therapy** (e.g., atezolizumab–bevacizumab, durvalumab–tremelimumab, sorafenib, lenvatinib, etc.)  

Curative local ablation (RFA/MWA) and standard TACE are generally **not** appropriate when there is major vascular invasion.","For a cirrhotic patient with hepatocellular carcinoma that is solitary or multifocal with vascular invasion, the criteria list these as appropriate or potentially appropriate:

Usually appropriate:
- Systemic therapies  
- Transarterial radioembolization (TARE)

May be appropriate:
- Transarterial chemoembolization (TACE)  
- Bland transarterial embolization (TAE)  
- Combination locoregional therapy  
- External beam radiation therapy (e.g., SBRT)

Usually not appropriate in this setting:
- Percutaneous liver ablation  
- Surgical liver resection  
- Liver transplantation","For a cirrhotic patient with hepatocellular carcinoma that is solitary or multifocal with vascular invasion (ACR Variant 4), the following are considered appropriate or potentially appropriate:

• Systemic therapies – Usually Appropriate  
• Transarterial radioembolization (TARE) – Usually Appropriate  
• Transarterial chemoembolization (TACE) – May Be Appropriate  
• Bland transarterial embolization (TAE) – May Be Appropriate  
• Combination locoregional therapy – May Be Appropriate  
• External beam radiation therapy (e.g., SBRT) – May Be Appropriate

The following are **not** considered appropriate in this setting:

• Percutaneous ablation – Usually Not Appropriate  
• Surgical liver resection – Usually Not Appropriate  
• Liver transplantation – Usually Not Appropriate"
"For a patient with iliocaval or lower extremity disease and severe post-thrombotic changes who is being treated, which listed interventions are considered NOT appropriate?","For iliocaval or lower extremity disease with severe post-thrombotic changes in the treatment setting, compression sclerotherapy is the only listed procedure that is considered Usually Not Appropriate.","For a patient with iliocaval or lower extremity disease and **severe post‑thrombotic changes**, the following are generally considered **NOT appropriate** interventions:

- **Catheter-directed thrombolysis (CDT)**  
- **Pharmacomechanical thrombectomy / mechanical thrombectomy**  
- **Surgical venous thrombectomy**

These acute thrombus-removal strategies are intended for relatively **fresh (acute or subacute) thrombus** and are not appropriate once severe chronic post‑thrombotic changes are present. Management in such cases focuses instead on chronic venous reconstruction (e.g., stenting if indicated), compression, and symptom control.","For a patient with iliocaval or lower extremity disease and severe post‑thrombotic changes who is **being treated**, the following listed interventions are **not appropriate** (i.e., not supported/indicated in this setting based on the provided context):

- **Endovenous ablation of superficial veins alone (EVLA/RFA, ligation and stripping, microphlebectomy, sclerotherapy)** as primary treatment for the post‑thrombotic iliocaval disease. These techniques address superficial reflux/varicose veins, not the central iliocaval obstruction that characterizes this variant.

- **Pelvic venous embolization or stenting** for pelvic-origin lower extremity varicose veins in this context, as the document notes little evidence of benefit for lower extremity disease.

The context supports, for treatment of iliocaval or lower extremity disease with severe post‑thrombotic changes, the use of:
- Therapeutic **anticoagulation**
- **Catheter-directed thrombolysis with or without thrombectomy** (in selected post‑thrombotic syndrome patients)
- **Iliac vein stenting** when a central iliocaval stenosis/occlusion is identified

Other listed superficial or pelvic varicose‑vein interventions are therefore not appropriate as the primary treatment for this specific post‑thrombotic iliocaval disease scenario.","For iliocaval or lower extremity disease with severe post‑thrombotic changes (Variant 8: Treatment), the ACR table does not label any of the listed treatment options as “Usually Not Appropriate.”

The ratings are:
- Anticoagulation – Usually Appropriate  
- Compression therapy – Usually Appropriate  
- Endovascular stenting – Usually Appropriate  
- Catheter-directed thrombolysis with or without thrombectomy – May Be Appropriate  
- Venous angioplasty – May Be Appropriate  
- Saphenous vein ablation – May Be Appropriate (Disagreement)  
- Venous bypass procedure – May Be Appropriate  
- Compression sclerotherapy – Usually Not Appropriate

Therefore, the only intervention specifically considered **NOT appropriate** for this indication is:
- **Compression sclerotherapy – Usually Not Appropriate**"
"In a cirrhotic patient with hepatocellular carcinoma and vascular invasion, how do systemic therapies compare with transarterial radioembolization in terms of appropriateness?","For hepatocellular cancer that is solitary or multifocal with vascular invasion in a cirrhotic patient, both systemic therapies and transarterial radioembolization are rated as Usually Appropriate.",,"For cirrhotic patients with hepatocellular carcinoma and vascular invasion (Variant 4 in the context):

- **Systemic therapies** are rated **“Usually Appropriate.”**  
- **Transarterial radioembolization (TARE)** is also rated **“Usually Appropriate.”**

So, in this specific setting, systemic therapy and TARE are considered comparably appropriate options. Other transarterial options (chemoembolization, bland embolization) and combination locoregional therapy are only “May Be Appropriate,” and surgery or transplantation are “Usually Not Appropriate.”","For a cirrhotic patient with hepatocellular carcinoma and vascular invasion (ACR Variant 4):

- **Systemic therapies** are rated **“Usually Appropriate.”**  
- **Transarterial radioembolization (TARE)** is also rated **“Usually Appropriate.”**

So, according to the criteria, systemic therapy and TARE are considered **equally appropriate** options for this indication in terms of appropriateness rating category, though choice between them depends on patient factors, liver function, tumor burden, and local expertise."
"You are trying to minimize radiation exposure in a cirrhotic patient with hepatocellular carcinoma and vascular invasion. Among the listed treatment options for this scenario, which ones do NOT inherently involve ionizing radiation?","For hepatocellular cancer that is solitary or multifocal with vascular invasion in a cirrhotic patient, the options that do not inherently involve ionizing radiation are:
- Systemic therapies
- Transarterial chemoembolization
- Bland transarterial embolization
- Combination locoregional therapy
Procedures that inherently involve ionizing radiation in this scenario include transarterial radioembolization and external beam radiation therapy.","Treatments that do **not** inherently involve ionizing radiation are:

- **Systemic therapies**  
  - Tyrosine kinase inhibitors (e.g., sorafenib, lenvatinib, regorafenib, cabozantinib)  
  - Immunotherapy (e.g., nivolumab, pembrolizumab, atezolizumab–bevacizumab, durvalumab–tremelimumab)  
  - Other systemic agents (e.g., ramucirumab in selected patients)

- **Locoregional therapies without radiation**  
  - Transarterial chemoembolization (TACE) – conventional or drug-eluting bead TACE  
  - Hepatic arterial infusion chemotherapy (HAIC)  
  - Systemic chemotherapy (if used)

By contrast, options that *do* inherently involve ionizing radiation include: external beam radiotherapy (e.g., SBRT), radioembolization (Y-90), and any CT-guided radiation-based procedures.","From the listed options for cirrhotic HCC with vascular invasion (Variant 4), the treatments that do NOT inherently involve ionizing radiation are:

- Systemic therapies (e.g., TKIs, immunotherapy)
- Transarterial chemoembolization (TACE)
- Bland transarterial embolization (TAE)
- Combination locoregional therapy when it consists of non‑radiation modalities (e.g., TACE plus microwave ablation)

The options that inherently use ionizing radiation are:

- Transarterial radioembolization (TARE)
- External beam radiation therapy (including SBRT)","For a cirrhotic patient with hepatocellular carcinoma and vascular invasion (the ACR Variant 4 scenario), the treatment options that **do not inherently involve ionizing radiation** are:

- **Systemic therapies** (e.g., systemic drugs such as TKIs, immunotherapy)
- **Percutaneous ablation** (e.g., radiofrequency ablation, microwave ablation)
- **Surgical liver resection**
- **Liver transplantation**

The following commonly listed options for this scenario *do* inherently use ionizing radiation and therefore would not be chosen if the goal is to minimize radiation exposure:
- Transarterial radioembolization (TARE)
- Transarterial chemoembolization (TACE)
- Bland transarterial embolization (TAE)
- Combination locoregional therapies (when they include catheter-based embolization or external beam radiation)
- External beam radiation therapy (including SBRT)"
"For a reproductive-age patient with uterine fibroids and concurrent adenomyosis who has heavy bleeding and bulk symptoms and no desire for future fertility, is laparoscopic uterine artery occlusion considered appropriate as initial therapy?",Laparoscopic uterine artery occlusion is rated as Usually Not Appropriate as initial therapy for a reproductive-age patient with uterine fibroids and concurrent adenomyosis who is symptomatic with heavy uterine bleeding or bulk symptoms and has no desire for future fertility.,"No. Laparoscopic uterine artery occlusion (LUAO) is generally **not** considered an appropriate *initial* therapy in this scenario.

For a reproductive‑age patient with:

- Symptomatic fibroids **and** adenomyosis  
- Heavy menstrual bleeding and bulk symptoms  
- No desire for future fertility  

the usual first‑line definitive surgical option is **hysterectomy** (often laparoscopic or vaginal, depending on uterine size and anatomy).

Key points:

- **Adenomyosis responds less predictably** to uterine artery–based therapies (LUAO or UAE) than fibroids do; pain and bleeding may persist.
- LUAO is less well‑studied and less standardized than uterine artery embolization (UAE), and both are typically considered **uterus‑preserving alternatives** for patients who wish to avoid hysterectomy.
- In a patient without fertility desires who has both heavy bleeding and bulk symptoms, guidelines and expert consensus generally favor **hysterectomy over uterine artery occlusion** as initial definitive treatment, assuming acceptable surgical risk.

LUAO might be considered only in selected patients who strongly wish to avoid hysterectomy and accept the risk of incomplete symptom control and possible need for later surgery.","No. For a reproductive‑age patient with uterine fibroids and concurrent adenomyosis, heavy bleeding and bulk symptoms, and no desire for future fertility, laparoscopic uterine artery occlusion is rated as “usually not appropriate” as initial therapy.  

Initial management should instead be medical therapy or uterine artery embolization.","No. For this exact scenario (reproductive‑age, uterine fibroids + concurrent adenomyosis, heavy bleeding and bulk symptoms, no desire for future fertility; initial therapy), **laparoscopic uterine artery occlusion is rated “Usually Not Appropriate.”**

Initial therapies considered **usually appropriate** instead are:
- Medical management
- Uterine artery embolization

Hysterectomy is only **may be appropriate**, and several other surgical or ablative options are also rated usually or may be not appropriate for this variant."
"For a patient presenting with varicose veins undergoing initial diagnostic evaluation, which imaging procedure is considered appropriate?","For initial diagnosis of varicose veins, US duplex Doppler lower extremity is rated as Usually Appropriate. All other listed imaging procedures for this scenario are not appropriate.",Duplex (color) Doppler ultrasonography of the lower extremity veins is the appropriate initial imaging procedure for evaluating varicose veins.,Ultrasound duplex Doppler of the lower extremity is the appropriate initial imaging procedure for a patient presenting with varicose veins.,"For a patient with varicose veins undergoing initial diagnostic evaluation, **duplex Doppler ultrasound of the lower extremity** is considered the appropriate imaging procedure (rated “Usually Appropriate”)."
"In the initial diagnostic workup of varicose veins, which of the listed imaging procedures are NOT considered appropriate?","For initial diagnosis of varicose veins, the following procedures are Usually Not Appropriate:
- Catheter venography iliac veins
- Catheter venography lower extremity
- CTV lower extremity with IV contrast
- CTV pelvis with IV contrast
- MRV lower extremity without and with IV contrast
- MRV pelvis without and with IV contrast
- US intravascular iliac veins","In the initial diagnostic workup of uncomplicated varicose veins, the following imaging procedures are **NOT** considered appropriate:

- **Venography** (contrast phlebography)  
- **CT venography**  
- **MR venography**  
- **Standard CT or MRI of the lower limbs**  
- **Arterial Doppler/arterial duplex** (since this evaluates arteries, not superficial venous disease)

The appropriate first-line imaging is **duplex (color) ultrasonography of the venous system**.","In the initial diagnostic workup of varicose veins, the following imaging procedures are **not** considered appropriate (i.e., not first-line):

- Catheter-directed venography of the iliac veins  
- Catheter-directed venography of the lower extremity  
- CT venography (CTV) of the lower extremity  
- CTV of the pelvis  
- MR venography (MRV) of the lower extremity  
- MRV of the pelvis  
- Intravascular ultrasound (IVUS) of the iliac veins  

The appropriate initial imaging test is duplex Doppler ultrasound of the lower extremity.","In the initial diagnostic workup of varicose veins, the following listed imaging procedures are **NOT** considered appropriate:

- Catheter venography of the iliac veins
- Catheter venography of the lower extremity
- CT venography (CTV) of the lower extremity with IV contrast
- CTV of the pelvis with IV contrast
- MR venography (MRV) of the lower extremity without and with IV contrast
- MRV of the pelvis without and with IV contrast
- Intravascular ultrasound (US intravascular) of the iliac veins

All of these are rated **“Usually Not Appropriate”** for initial diagnosis of varicose veins. The only procedure rated “Usually Appropriate” is duplex Doppler ultrasound of the lower extremity."
"For a patient with suspected varicose veins at the stage of initial diagnosis, how does US duplex Doppler of the lower extremity compare with catheter venography of the lower extremity in terms of appropriateness?","For initial diagnosis of varicose veins, US duplex Doppler lower extremity is rated as Usually Appropriate, whereas catheter venography lower extremity is rated as Usually Not Appropriate.","For initial diagnosis of suspected varicose veins:

- **US duplex Doppler of the lower extremity** – **Usually appropriate / first-line test.**  
  - Noninvasive, no contrast, maps reflux and anatomy, guides treatment planning.  
  - Recommended as the primary imaging modality in most guidelines.

- **Catheter venography of the lower extremity** – **Usually not appropriate for initial diagnosis.**  
  - Invasive, uses iodinated contrast and radiation.  
  - Reserved for complex or equivocal cases, pre‑interventional planning when duplex is inadequate, or when deep venous obstruction is strongly suspected and noninvasive tests are inconclusive.

So, for a patient at the stage of initial diagnosis of suspected varicose veins, **duplex ultrasound is preferred and considered appropriate; catheter venography is generally inappropriate as an initial study.**","For initial diagnosis of suspected varicose veins:

- **US duplex Doppler of the lower extremity** is rated **“Usually Appropriate”** and is recommended as the first-line imaging test.
- **Catheter venography of the lower extremity** is rated **“Usually Not Appropriate”** for this indication.

So, duplex ultrasound is preferred and considered appropriate; catheter venography is generally inappropriate at the initial diagnostic stage.","For initial diagnosis of suspected varicose veins:

- **US duplex Doppler of the lower extremity** is rated **“Usually Appropriate”** and is the recommended first-line imaging test.
- **Catheter venography of the lower extremity** is rated **“Usually Not Appropriate”** and is not recommended for routine initial diagnostic evaluation.

So, duplex Doppler ultrasound is preferred and considered appropriate; catheter venography is generally inappropriate at this stage."
"A clinician wants to minimize radiation exposure when evaluating a patient with varicose veins at initial presentation. Among the listed imaging options for this scenario, which test is both appropriate and avoids ionizing radiation?","For initial diagnosis of varicose veins, US duplex Doppler lower extremity is the only procedure that is rated as Usually Appropriate and it avoids ionizing radiation. All other listed options (catheter venography, CTV, and MRV variants, and intravascular US) are rated as Usually Not Appropriate for this scenario.",Duplex (color) **ultrasound** of the lower extremity veins is the appropriate initial test and does not involve ionizing radiation.,Duplex Doppler ultrasound of the lower extremities is the appropriate initial imaging test and avoids ionizing radiation.,"For a patient with varicose veins at initial presentation, the imaging test that is both **appropriate** and **avoids ionizing radiation** is:

- **Ultrasound (US) duplex Doppler of the lower extremity**

It is rated “Usually Appropriate” for initial diagnosis of varicose veins and uses no ionizing radiation (unlike CT/CTV) and is preferred over catheter venography, which is invasive and uses radiation."
"For a pregnant patient with acute iliofemoral DVT and moderate to severe symptoms, how is anticoagulation alone rated for appropriateness?","For acute iliofemoral DVT in a pregnant patient with moderate to severe symptoms, anticoagulation alone is rated as Usually Appropriate.","For a pregnant patient with acute iliofemoral DVT and **moderate to severe symptoms**, **anticoagulation alone is rated as “May Be Appropriate” (M)** rather than clearly appropriate or inappropriate.",Anticoagulation alone is rated as **“Usually Appropriate”** for a pregnant patient with acute iliofemoral DVT and moderate to severe symptoms.,"For a pregnant patient with acute iliofemoral DVT and moderate to severe symptoms, **anticoagulation alone is rated “Usually Appropriate.”**"
"In a pregnant patient with acute iliofemoral DVT and moderate to severe symptoms, which of the listed treatment options are considered appropriate to use (at any level of appropriateness)?","For acute iliofemoral DVT in a pregnant patient with moderate to severe symptoms, the following procedures are considered appropriate at some level:
- Anticoagulation alone (Usually Appropriate)
- CDT/PMT with or without stent placement (May Be Appropriate)
- Graded compression stocking therapy (May Be Appropriate)
- Surgical thrombectomy with or without stent placement (May Be Appropriate)","For a pregnant patient with acute iliofemoral DVT and moderate–severe symptoms, the following are considered appropriate (at least “may be appropriate”) in major guidelines/appropriate-use criteria:

1. **Therapeutic anticoagulation alone** (e.g., LMWH) – appropriate first-line therapy.  
2. **Catheter-directed thrombolysis (CDT)** – may be appropriate in selected cases (severe symptoms, low bleeding risk, good life expectancy, and in experienced centers).  
3. **Pharmacomechanical catheter-directed thrombolysis (PCDT)** – similarly may be appropriate in carefully selected, severely symptomatic patients.  
4. **Temporary/retrievable IVC filter** – may be appropriate only if anticoagulation is contraindicated or impossible (e.g., active major bleeding, urgent surgery).

The following are generally **not appropriate** solely for DVT in pregnancy:
- Systemic thrombolysis (except in life-threatening PE, not isolated DVT).
- Routine permanent IVC filter placement when anticoagulation is feasible.","For a pregnant patient with acute iliofemoral DVT and moderate to severe symptoms, the following options are considered appropriate at some level:

- Anticoagulation alone – usually appropriate  
- Catheter-directed thrombolysis / pharmacomechanical thrombectomy (CDT/PMT) with or without stent placement – may be appropriate  
- Graded compression stocking therapy – may be appropriate  
- Surgical thrombectomy with or without stent placement – may be appropriate","For a pregnant patient with acute iliofemoral DVT and moderate to severe symptoms (Variant 7), the following treatment options are considered appropriate at some level (ie, not “Usually Not Appropriate”):

- **Anticoagulation alone** – Usually Appropriate
- **Catheter-directed thrombolysis / pharmacomechanical thrombectomy (CDT/PMT) with or without stent placement** – May Be Appropriate
- **Graded compression stocking therapy** – May Be Appropriate
- **Surgical thrombectomy with or without stent placement** – May Be Appropriate"
"For the scenario of suspected thrombosis of an upper or lower extremity hemodialysis access, marked by absent pulse and thrill on exam, which of the procedures listed in the data is NOT considered appropriate for this indication?","Based only on the provided data, no procedures are labeled as inappropriate for suspected thrombosis of upper or lower extremity hemodialysis access. The only procedure given for this scenario is placement of a new tunneled dialysis catheter, which is rated as May Be Appropriate.","The procedure that is **not** appropriate for suspected thrombosis of a hemodialysis access (absent pulse and thrill) is:

**Duplex ultrasound of the extremity veins** (i.e., routine venous duplex for DVT evaluation).

For a thrombosed dialysis access, appropriate procedures include **fistulogram/graftogram with possible thrombectomy or angioplasty**, not a standard extremity venous duplex study.",US duplex Doppler of the hemodialysis access area of interest is NOT considered appropriate for this indication (it is rated “Usually Not Appropriate”).,"For suspected thrombosis of an upper or lower extremity hemodialysis access with absent pulse and thrill, **US duplex Doppler of the hemodialysis access** is the procedure that is **NOT considered appropriate** when the question is treatment/procedures. It is rated **“Usually Not Appropriate”** for this indication.

(For this variant, the appropriate treatment options are fluoroscopy fistulography with intervention and surgical consultation, with placement of a new tunneled dialysis catheter rated May Be Appropriate.)"
"In a pregnant patient with acute iliofemoral DVT and moderate to severe symptoms, how do anticoagulation alone and CDT/PMT with or without stent placement compare in terms of appropriateness?","For acute iliofemoral DVT in a pregnant patient with moderate to severe symptoms, anticoagulation alone is rated as Usually Appropriate, whereas CDT/PMT with or without stent placement is rated as May Be Appropriate.",,"For a pregnant patient with acute iliofemoral DVT and moderate to severe symptoms:

- **Anticoagulation alone** (with low–molecular weight heparin) is rated **“Usually Appropriate”** and is considered first-line therapy.
- **CDT/PMT with or without stent placement** is rated **“May Be Appropriate”** rather than “Usually Appropriate.”

Catheter-directed or mechanical thrombectomy is reserved for selected cases with severe, persistent symptoms that do not improve after a trial of anticoagulation, particularly in the second or third trimester, given radiation and safety concerns.","In a pregnant patient with acute iliofemoral DVT and moderate to severe symptoms (Variant 7), the ACR Appropriateness Criteria rate them as follows:

- **Anticoagulation alone** – **Usually Appropriate**
- **CDT/PMT with or without stent placement** – **May Be Appropriate**

So anticoagulation alone is preferred and has a higher appropriateness rating than CDT/PMT, which is reserved for selected cases (e.g., severe, refractory symptoms after a trial of anticoagulation)."
"You are concerned about radiation exposure in a pregnant patient with acute iliofemoral DVT and moderate to severe symptoms. Among the listed treatment options, which non–catheter-based therapies are considered appropriate and might avoid radiation exposure?","For acute iliofemoral DVT in a pregnant patient with moderate to severe symptoms, the non–catheter-based therapies that are considered appropriate and may avoid radiation exposure are:
- Anticoagulation alone (Usually Appropriate)
- Graded compression stocking therapy (May Be Appropriate)","For a pregnant patient with acute iliofemoral DVT and moderate–severe symptoms, the non–catheter-based options that are appropriate and avoid radiation exposure are:

- **Therapeutic anticoagulation alone** (e.g., weight-based LMWH)  
- **Anticoagulation plus compression therapy and early ambulation**

These systemic, non–catheter-based approaches do not require fluoroscopy or other ionizing radiation.","For a pregnant patient with acute iliofemoral DVT and moderate to severe symptoms, the non–catheter-based therapies that are considered appropriate and can avoid radiation exposure are:

- Anticoagulation alone with low molecular weight heparin  
- Graded compression stocking therapy (for comfort/symptom management, in addition to anticoagulation)  
- Surgical thrombectomy with or without temporary arteriovenous fistula creation (considered in severe, refractory cases specifically to avoid radiation)","For a pregnant patient with acute iliofemoral DVT and moderate to severe symptoms, the non–catheter-based therapies that are considered appropriate and can avoid radiation exposure are:

- **Anticoagulation alone** – Usually Appropriate
- **Graded compression stocking therapy** – May Be Appropriate

Both are noninvasive, non–catheter-based options and do not require ionizing radiation."
"For follow-up after open repair of a thoracoabdominal aortic aneurysm or dissection, how is an MRA of the chest, abdomen, and pelvis performed without and with IV contrast rated for appropriateness?","For this scenario, MRA chest abdomen pelvis without and with IV contrast is rated as Usually Appropriate.","For follow-up after open repair of a thoracoabdominal aortic aneurysm or dissection, an MRA of the chest, abdomen, and pelvis without and with IV contrast is generally rated as:

**Usually Appropriate**

This is based on ACR Appropriateness Criteria for postoperative imaging of thoracic and thoracoabdominal aorta, where contrast-enhanced MRA of the chest/abdomen/pelvis is considered an appropriate modality for surveillance after open repair.",It is rated as **“Usually Appropriate.”**,"For follow-up after open repair of a thoracoabdominal aortic aneurysm or dissection, **MRA of the chest, abdomen, and pelvis performed without and with IV contrast is rated “Usually Appropriate.”**"
"In a patient who has undergone open repair of a thoracoabdominal aortic aneurysm or dissection and is now presenting for imaging follow-up, which imaging procedures are considered Usually Appropriate for this indication?","For follow-up after open repair of thoracoabdominal aortic aneurysm or dissection, the following procedures are Usually Appropriate:
- MRA chest abdomen pelvis without and with IV contrast
- CTA chest abdomen pelvis with IV contrast","For follow-up after **open repair of a thoracoabdominal aortic aneurysm or dissection**, the ACR Appropriateness Criteria list the following as **Usually Appropriate**:

- **CTA chest and abdomen with IV contrast**  
- **MRA chest and abdomen with IV contrast**

These are the primary recommended imaging modalities for surveillance in this setting.","For follow-up after **open repair of a thoracoabdominal aortic aneurysm or dissection**, the imaging procedures considered **Usually Appropriate** are:

- **MRA chest, abdomen, and pelvis without and with IV contrast**, or  
- **CTA chest, abdomen, and pelvis with IV contrast**

These are regarded as equivalent alternatives; typically only one would be ordered for a given follow-up evaluation.","For follow-up after open repair of a thoracoabdominal aortic aneurysm or dissection (Variant 4), the imaging procedures considered **Usually Appropriate** are:

- **MRA chest, abdomen, and pelvis without and with IV contrast**
- **CTA chest, abdomen, and pelvis with IV contrast**"
"For follow-up after open repair of a thoracoabdominal aortic aneurysm or dissection, which imaging or diagnostic procedures are rated as Usually Not Appropriate?","For this follow-up scenario, the following procedures are Usually Not Appropriate:
- US duplex Doppler aorta abdomen
- US echocardiography transthoracic resting
- Radiography chest
- Radiography chest abdomen pelvis
- Aortography chest abdomen pelvis
- CT chest and abdomen without IV contrast","For follow-up after open repair of a thoracoabdominal aortic aneurysm or dissection, the following are rated **Usually Not Appropriate** (per ACR Appropriateness Criteria):

- **MRA chest without and with IV contrast**  
- **MRA chest without IV contrast**  
- **MRA abdomen and pelvis without and with IV contrast**  
- **MRA abdomen and pelvis without IV contrast**  
- **MRI chest without and with IV contrast**  
- **MRI chest without IV contrast**  
- **MRI abdomen and pelvis without and with IV contrast**  
- **MRI abdomen and pelvis without IV contrast**  
- **Transthoracic echocardiography (TTE)**  
- **Transesophageal echocardiography (TEE)**  
- **Catheter aortography**  

In this setting, **CT angiography (CTA) of the chest/abdomen/pelvis** is typically the modality rated as Usually Appropriate.","For follow-up after open repair of a thoracoabdominal aortic aneurysm or dissection (Variant 4), no specific imaging or diagnostic procedures are rated as “Usually Not Appropriate” in the provided context.","For follow-up after open repair of a thoracoabdominal aortic aneurysm or dissection, the following imaging/diagnostic procedures are rated as **Usually Not Appropriate**:

- US duplex Doppler aorta abdomen
- US echocardiography transthoracic resting
- Radiography chest
- Radiography chest, abdomen, and pelvis
- Aortography chest, abdomen, and pelvis
- CT chest and abdomen without IV contrast"
"In the setting of follow-up after open repair of a thoracoabdominal aortic aneurysm or dissection, how do MRA chest abdomen pelvis without and with IV contrast and CTA chest abdomen pelvis with IV contrast compare in terms of appropriateness and relative radiation level?","For this follow-up scenario:
- MRA chest abdomen pelvis without and with IV contrast is Usually Appropriate and has a relative radiation level (RRL) of 0.
- CTA chest abdomen pelvis with IV contrast is also Usually Appropriate but has a relative radiation level (RRL) of 5.
Thus, both are usually appropriate, but MRA has no associated radiation exposure, whereas CTA has high radiation exposure.","For follow-up after open repair of a thoracoabdominal aortic aneurysm or dissection (postoperative surveillance):

- **CTA chest/abdomen/pelvis with IV contrast**  
  - **Appropriateness**: Usually **“Usually Appropriate”** (often the reference standard).  
  - **Radiation**: **High** radiation level (multiple-region CT angiography).

- **MRA chest/abdomen/pelvis without and with IV contrast**  
  - **Appropriateness**: Also typically **“Usually Appropriate”** as an alternative, especially when avoiding radiation or iodinated contrast is important.  
  - **Radiation**: **No radiation** (MRI-based exam).

So: both are generally considered appropriate for follow-up imaging; CTA has high radiation exposure, whereas MRA has none.","For follow-up after **open** repair of a thoracoabdominal aortic aneurysm or dissection:

- **MRA chest/abdomen/pelvis without and with IV contrast**  
  - **Appropriateness:** Usually Appropriate  
  - **Relative radiation level:** O (no ionizing radiation)

- **CTA chest/abdomen/pelvis with IV contrast**  
  - **Appropriateness:** Usually Appropriate  
  - **Relative radiation level:** ☢☢☢☢☢ (highest radiation category listed)","In follow-up after open repair of a thoracoabdominal aortic aneurysm or dissection (Variant 4):

• **MRA chest abdomen pelvis without and with IV contrast**  
  - **Appropriateness category:** Usually Appropriate  
  - **Relative radiation level:** O (no ionizing radiation)

• **CTA chest abdomen pelvis with IV contrast**  
  - **Appropriateness category:** Usually Appropriate  
  - **Relative radiation level:** ☢☢☢☢☢ (highest radiation category among the listed options)

Thus, both are considered *equally appropriate* for this indication, but MRA has **no radiation exposure**, whereas CTA involves **substantial ionizing radiation**."
"A patient with suspected dysfunction of an upper extremity hemodialysis arteriovenous fistula, based on reduced access blood flow, needs evaluation and potential treatment. Among the listed options, which are considered Usually Appropriate and do not involve ionizing radiation exposure?","For suspected dysfunction of upper or lower extremity hemodialysis access with abnormal clinical or hemodynamic indicators, the following are Usually Appropriate and do not involve ionizing radiation:
- US duplex Doppler hemodialysis access area of interest
- Fluoroscopy fistulography hemodialysis access with intervention does involve ionizing radiation, so it is not a low-radiation option.
Therefore, the only low- or no-radiation Usually Appropriate option is US duplex Doppler hemodialysis access area of interest.","The options that are **Usually Appropriate** and **do not involve ionizing radiation** are:

- **Duplex ultrasound (Doppler ultrasound) of the hemodialysis access**  
- **MR angiography (MRA) of the upper extremity/fistula without ionizing radiation** (i.e., noncontrast or gadolinium-enhanced MRA, not CT-based)","The options that are **Usually Appropriate** and **do not involve ionizing radiation** are:

- **Ultrasound (US) duplex Doppler of the hemodialysis access (area of interest)** for:
  - Initial imaging to evaluate suspected dysfunction (Variant 1)  
  - Treatment planning/therapeutic guidance in suspected dysfunction (Variant 2)","For a patient with suspected dysfunction of an upper extremity hemodialysis AV fistula (based on reduced access blood flow) who needs evaluation and potential treatment, the options that are **Usually Appropriate** and **do not involve ionizing radiation** are:

- **US duplex Doppler hemodialysis access, area of interest**

Fluoroscopy fistulography (diagnostic or with intervention) is also Usually Appropriate for this indication, but it uses ionizing radiation, so it does not meet your “no radiation” criterion."
"For the patient with a post–left hemicolectomy abdominal abscess whose drain output is 25 cc/day and whose collection is unchanged on CT despite antibiotics, how is catheter upsizing rated for this scenario?",Catheter upsizing is rated as Usually Appropriate.,"In this scenario, catheter upsizing is rated **“May Be Appropriate”** (appropriateness score: **4–6**), rather than “Usually Appropriate,” because:

- The drain is still functioning (25 cc/day output).
- The collection is unchanged on CT despite antibiotics, suggesting possible inadequate drainage or catheter position/size issues.
- Upsizing can be considered, but it is not mandatory; other options (repositioning, additional drainage, or continued observation depending on clinical status) may also be reasonable.",Catheter upsizing is rated as “Usually Appropriate” for this scenario.,"For this post–left hemicolectomy patient with a persistent abdominal abscess (low drain output and no change in collection size on CT despite antibiotics), **catheter upsizing is rated as Usually Appropriate.**"
"In the scenario of a cirrhotic patient with hepatocellular carcinoma characterized by a solitary 3–5 cm tumor, list all procedures that are considered Usually Appropriate treatment options.","For a cirrhotic patient with hepatocellular cancer and a solitary 3–5 cm tumor, the procedures that are Usually Appropriate are:
- Liver transplantation
- Combination locoregional therapy
- Surgical liver resection
- Transarterial chemoembolization
- Transarterial radioembolization","For a cirrhotic patient with hepatocellular carcinoma and a solitary 3–5 cm tumor, the following are considered **Usually Appropriate** treatment options:

1. **Surgical resection** (if liver function and portal pressure allow)  
2. **Liver transplantation** (if within transplant criteria, e.g., Milan criteria)  
3. **Thermal ablation** (radiofrequency or microwave ablation)  
4. **Transarterial chemoembolization (TACE)**  
5. **Stereotactic body radiation therapy (SBRT)** (in selected patients where other locoregional therapies are not suitable)","For a cirrhotic patient with hepatocellular carcinoma and a solitary 3–5 cm tumor, the procedures considered Usually Appropriate are:

- Liver transplantation  
- Combination locoregional therapy (ablation plus TACE or TAE)  
- Surgical liver resection  
- Transarterial chemoembolization (TACE)  
- Transarterial radioembolization (TARE)","For a cirrhotic patient with hepatocellular carcinoma characterized by a solitary 3–5 cm tumor, the following procedures are considered **Usually Appropriate** treatment options:

- Liver transplantation  
- Combination locoregional therapy (e.g., ablation plus transarterial therapy)  
- Surgical liver resection  
- Transarterial chemoembolization (TACE)  
- Transarterial radioembolization (TARE)

All other listed options for this variant are rated May Be Appropriate or Usually Not Appropriate."
"For the patient with a post–left hemicolectomy abdominal abscess and a drain in place (low output, unchanged collection on CT, on antibiotics), which management options are NOT considered appropriate (i.e., rated Usually Not Appropriate) in this setting?","In this scenario, the management option that is Usually Not Appropriate is:
- Continued antibiotics and drain removal","In this scenario (post–left hemicolectomy abdominal abscess, drain in place with low output, unchanged collection on CT, on antibiotics), the following options are **Usually Not Appropriate**:

- **Repeat CT scan with IV contrast** (no clinical change, collection unchanged, drain already in place)  
- **Repeat image-guided percutaneous drainage** of the same collection (no evidence of undrained loculations or enlarging abscess)  
- **Immediate surgical re-exploration/laparotomy** solely for the stable residual collection  
- **Removal of the existing drain** when the collection is unchanged and still present on imaging  

These are rated “Usually Not Appropriate” in the absence of clinical deterioration or imaging evidence of a new/enlarging or inadequately drained collection.","In this post–left hemicolectomy patient with a persistent abdominal abscess and a drain in place, the option rated **Usually Not Appropriate** is:

- **Continued antibiotics and drain removal**","In this scenario (post–left hemicolectomy abdominal abscess, drain in place, output 25 cc/day, collection unchanged on CT, on antibiotics), the management option that is **NOT** considered appropriate—i.e., rated **Usually Not Appropriate**—is:

- **Continued antibiotics and drain removal**

All other listed options for this variant (catheter upsizing, intracavitary thrombolytic therapy and drainage, continued antibiotics and drainage with no change in care, laparoscopic drainage, open surgical drainage) are rated May Be Appropriate or Usually Appropriate, not Usually Not Appropriate."
"In a cirrhotic patient with a solitary 3–5 cm hepatocellular carcinoma, how do transarterial chemoembolization and bland transarterial embolization compare in terms of appropriateness?","For a cirrhotic patient with a solitary 3–5 cm hepatocellular carcinoma:
- Transarterial chemoembolization is Usually Appropriate.
- Bland transarterial embolization is May Be Appropriate.","For a cirrhotic patient with a solitary 3–5 cm HCC:

- **Both TACE and bland TAE (embolization alone) are considered appropriate locoregional options** when the tumor is not amenable to curative therapy (resection, ablation, or transplant) and there is preserved liver function (typically Child–Pugh A/B, no main portal vein thrombosis, no decompensated cirrhosis).

- **Guidelines (AASLD, EASL, NCCN)** generally:
  - List **conventional TACE or drug-eluting bead TACE** as the standard transarterial therapy for intermediate-stage HCC and for some early-stage tumors not suitable for curative options.
  - Consider **bland TAE** an acceptable alternative when chemotherapy is contraindicated or not available, but it is less strongly endorsed.

- **Evidence**:
  - Multiple studies and meta-analyses show **no consistent survival advantage of TACE over bland TAE**, though TACE may have slightly higher objective response rates in some series.
  - Toxicity and post-embolization syndrome are similar; TACE may have somewhat higher systemic toxicity due to chemotherapy.

**Practical takeaway**:  
For a solitary 3–5 cm HCC in a cirrhotic patient who is not a candidate for resection/ablation/transplant, **TACE is usually preferred and guideline-backed as first-line**, but **bland TAE is a reasonable and often “appropriate” alternative**, especially if there are concerns about chemotherapy tolerance or institutional preference/experience with TAE.","For a cirrhotic patient with a solitary 3–5 cm hepatocellular carcinoma:

- Transarterial chemoembolization (TACE) is rated **“Usually Appropriate”**.
- Bland transarterial embolization (TAE) is rated **“May Be Appropriate”**.

So TACE is considered more appropriate and preferred over bland TAE in this setting, though bland TAE can still be considered when TACE is not suitable.","For a cirrhotic patient with a solitary 3–5 cm hepatocellular carcinoma:

- **Transarterial chemoembolization (TACE)** is rated **Usually Appropriate**.
- **Bland transarterial embolization (TAE)** is rated **May Be Appropriate**.

So TACE is considered more appropriate than bland TAE in this specific scenario."
"You are trying to minimize radiation exposure in a cirrhotic patient with a solitary 3–5 cm hepatocellular carcinoma. Among the listed treatment options for this scenario, which therapies do not inherently involve external beam or intra-arterial radiation delivery and how are they rated for appropriateness?","In a cirrhotic patient with a solitary 3–5 cm hepatocellular carcinoma, the options that do not inherently involve external beam or intra-arterial radiation and their appropriateness ratings are:
- Liver transplantation: Usually Appropriate
- Combination locoregional therapy (non-specified mix, may or may not include radiation depending on components): Usually Appropriate
- Surgical liver resection: Usually Appropriate
- Transarterial chemoembolization: Usually Appropriate
- Bland transarterial embolization: May Be Appropriate
- Percutaneous ablation liver: May Be Appropriate
- Systemic therapies: Usually Not Appropriate

The explicitly radiation-based options in this scenario are:
- Transarterial radioembolization: Usually Appropriate
- External beam radiation therapy: May Be Appropriate",,"For a cirrhotic patient with a solitary 3–5 cm HCC (Variant 2), the listed options that do **not** inherently involve external beam or intra‑arterial radiation are:

- **Liver transplantation** – rated **Usually Appropriate**  
- **Combination locoregional therapy (ablation + TACE/TAE)** – **Usually Appropriate**  
- **Surgical liver resection** – **Usually Appropriate**  
- **Transarterial chemoembolization (TACE)** – **Usually Appropriate**  
- **Bland transarterial embolization (TAE)** – **May Be Appropriate**  
- **Percutaneous liver ablation** – **May Be Appropriate**  

The therapies that *do* involve radiation are external beam radiation therapy and transarterial radioembolization.","For a cirrhotic patient with a solitary 3–5 cm hepatocellular carcinoma (Variant 2), the listed treatment options that **do not inherently involve external beam or intra‑arterial radiation delivery** and their ACR appropriateness ratings are:

Non‑radiation therapies:
- **Liver transplantation** – Usually Appropriate  
- **Surgical liver resection** – Usually Appropriate  
- **Combination locoregional therapy (e.g., ablation + TACE/TAE)** – Usually Appropriate  
- **Transarterial chemoembolization (TACE)** – Usually Appropriate  
- **Bland transarterial embolization (TAE)** – May Be Appropriate  
- **Percutaneous liver ablation** – May Be Appropriate  
- **Systemic therapies** – Usually Not Appropriate

Therapies that *do* involve radiation (for contrast):
- **External beam radiation therapy (e.g., SBRT)** – May Be Appropriate  
- **Transarterial radioembolization (TARE, Y‑90)** – Usually Appropriate

So, if you are specifically trying to avoid radiation, the usually appropriate non‑radiation options are liver transplantation, surgical resection, combination locoregional therapy, and TACE; TAE and percutaneous ablation are additional non‑radiation options rated May Be Appropriate in this scenario."
"For a female patient with pelvic-origin lower extremity varicose veins, how is iliac vein stenting rated for treatment in this scenario?","In the scenario of pelvic-origin lower extremity varicose veins in females (treatment), iliac vein stenting is rated as Usually Not Appropriate.","For pelvic-origin lower extremity varicose veins (e.g., from iliac vein obstruction/May–Thurner), iliac vein stenting is generally considered:

- **An accepted but selective treatment**, not first-line for all varicose veins.
- **Appropriate when**:
  - There is documented iliac vein obstruction (by venography/IVUS, sometimes CT/MR venography).
  - Symptoms are significant (pain, swelling, venous claudication, recurrent varicose veins, venous ulcers).
  - Conservative and/or superficial venous treatments alone are insufficient.
- **Guideline perspective** (SVS/AVF/AVLS, ESVS):
  - Endovascular stenting for non-thrombotic iliac vein lesions is **recommended/endorsed** in symptomatic patients with hemodynamically significant obstruction.
  - For varicose veins specifically, stenting is viewed as **adjunctive**—treat the obstructive pelvic outflow lesion first when present, then address residual superficial varicosities.

In short, iliac vein stenting is rated as an evidence-supported, guideline-endorsed option for appropriately selected women with pelvic-origin varicose veins due to iliac obstruction, but not a routine treatment for typical primary leg varicose veins.","Iliac vein stenting is not supported by evidence for treating pelvic-origin lower extremity varicose veins in women. 

The guideline states there is no relevant or high‑quality data demonstrating benefit of iliac vein stenting for improving pelvic-origin leg varicosities or their symptoms, so it is not recommended as a standard treatment in this scenario.","For a female patient with pelvic-origin lower extremity varicose veins (Variant 6, treatment), **iliac vein stenting is rated “Usually Not Appropriate.”**"
"In a woman with pelvic-origin lower extremity varicose veins who is being evaluated for treatment options, which procedures are considered appropriate or potentially appropriate according to the criteria?","For pelvic-origin lower extremity varicose veins in females (treatment), the procedures considered appropriate or potentially appropriate are:
- Conservative management: Usually Appropriate
- Compression sclerotherapy: May Be Appropriate
- Microphlebectomy: May Be Appropriate
- Saphenous vein ablation: May Be Appropriate (Disagreement)
- Iliac vein embolization: May Be Appropriate","For a woman with pelvic-origin lower extremity varicose veins, the following are considered appropriate or potentially appropriate treatment options:

**Appropriate:**
- Endovenous embolization of incompetent pelvic veins (e.g., ovarian or internal iliac vein embolization) when pelvic venous reflux is documented and symptoms correlate.
- Endovenous ablation (thermal or nonthermal) of refluxing lower extremity truncal veins when there is associated leg varicosity and documented reflux.
- Adjunctive phlebectomy or sclerotherapy of residual varicose tributaries after treatment of the primary reflux source.

**Potentially appropriate (depending on anatomy, symptoms, and prior treatment):**
- Repeat or staged pelvic vein embolization if initial treatment was incomplete or if there is recurrence.
- Surgical ligation of pelvic escape points or refluxing pelvic veins when endovascular options are not feasible.
- Conservative therapy (compression, lifestyle modification) as adjunctive management or when invasive treatment is deferred.

These align with commonly used appropriate use criteria for chronic venous disease and pelvic venous disorders.","For a woman with pelvic-origin lower extremity varicose veins being evaluated for treatment, the following are considered appropriate or potentially appropriate:

- **Saphenous vein ablation** (typically after pelvic embolization/sclerotherapy when indicated)  
- **Compression sclerotherapy** (foam sclerotherapy of pelvic-origin varices, often combined with embolization)  

These are the procedures specifically listed under treatment for pelvic-origin lower extremity varicose veins in females.","For a woman with pelvic-origin lower extremity varicose veins who is being evaluated for treatment (Variant 6: Treatment), the procedures rated as appropriate or potentially appropriate are:

- **Conservative management** – Usually Appropriate
- **Compression sclerotherapy** – May Be Appropriate
- **Microphlebectomy** – May Be Appropriate
- **Saphenous vein ablation** – May Be Appropriate (Disagreement)
- **Iliac vein embolization** – May Be Appropriate

All other listed options in this scenario (iliac vein stenting, left renal vein stenting, left renal vein surgery, ovarian vein embolization, iliac vein surgery) are rated **Usually Not Appropriate** for treatment of pelvic-origin lower extremity varicose veins in women."
"For suspected vascular steal syndrome related to hemodialysis access, suggested by cardiac failure or ischemic symptoms, which listed procedures are NOT considered appropriate for treatment or evaluation?","In the scenario of suspected vascular steal syndrome (upper or lower extremity), suggested by cardiac failure or ischemic symptoms (treatment and procedures), the procedure that is not considered appropriate is:
- US duplex Doppler hemodialysis access area of interest: Usually Not Appropriate","Procedures that are **not** considered appropriate for treatment or evaluation of suspected hemodialysis access–related vascular steal (suggested by cardiac failure or ischemic symptoms) include:

- **Arteriography of the access** (diagnostic angiography of the fistula/graft itself)  
- **Percutaneous transluminal angioplasty (PTA) of the access**  
- **Stent placement in the access**  

These endovascular interventions on the access are not appropriate as primary evaluation/treatment for suspected steal syndrome in this context.","For suspected vascular steal syndrome related to hemodialysis access:

From the “Treatment and procedures” list (Variant 12), the procedure that is **NOT** considered appropriate is:

- **US duplex Doppler hemodialysis access area of interest** – rated “Usually Not Appropriate.”

The other listed procedures (surgical consultation, continued access use with surveillance, fluoroscopy fistulography with intervention, and placement of a new tunneled dialysis catheter) are considered “Usually Appropriate” or “May Be Appropriate,” not “Usually Not Appropriate.”","For suspected vascular steal syndrome related to hemodialysis access, suggested by cardiac failure or ischemic symptoms, the ACR Appropriateness Criteria give two relevant variants:

1. **Variant 11 – Initial imaging to guide interventional radiologic therapy options**  
   The following procedures are **NOT considered appropriate (Usually Not Appropriate)** for evaluation:
   - MRA extremity area of interest without and with IV contrast  
   - MRA extremity area of interest without IV contrast  
   - MRV extremity area of interest without and with IV contrast  
   - MRV extremity area of interest without IV contrast  
   - CTV extremity area of interest with IV contrast

2. **Variant 12 – Treatment and procedures**  
   The following procedure is **NOT considered appropriate (Usually Not Appropriate)** for treatment in this context:
   - US duplex Doppler hemodialysis access area of interest

All of the above are rated “Usually Not Appropriate” for this clinical scenario."
"In a female patient with pelvic-origin lower extremity varicose veins being considered for interventional treatment, how do saphenous vein ablation and iliac vein embolization compare in terms of appropriateness?","For pelvic-origin lower extremity varicose veins in females (treatment):
- Saphenous vein ablation is rated May Be Appropriate (Disagreement).
- Iliac vein embolization is rated May Be Appropriate.
Both are considered potentially appropriate options, but saphenous vein ablation carries noted disagreement among experts, whereas iliac vein embolization does not.",,"For pelvic-origin lower extremity varicose veins in a female patient:

- **Saphenous vein ablation** is rated **“May Be Appropriate (Disagreement)”** for this indication. It is generally used **after** pelvic venous insufficiency has been treated (e.g., embolization/sclerotherapy of gonadal and pelvic veins) and mainly addresses residual saphenous reflux in the legs, not the primary pelvic source.

- **Iliac vein embolization** is rated simply **“May Be Appropriate”** (without disagreement). It directly targets pelvic venous insufficiency and is considered a reasonable interventional option for treating pelvic-origin varicose veins, although high‑quality outcome data are limited.

So, for primary interventional management of pelvic-origin lower extremity varicose veins, iliac vein embolization is considered more directly appropriate, whereas saphenous vein ablation is a secondary or adjunctive option and more controversial in this specific setting.","In this scenario (female with pelvic-origin lower extremity varicose veins, treatment/“Variant 6”):

- **Saphenous vein ablation** – rated **“May Be Appropriate (Disagreement)”**
- **Iliac vein embolization** – rated **“May Be Appropriate”**

So both are considered potentially appropriate options, but iliac vein embolization has a straightforward “May Be Appropriate” rating, whereas saphenous vein ablation carries a “May Be Appropriate” rating **with panel disagreement**, indicating more variability in expert opinion about its use in this specific pelvic-origin context."
"A patient on hemodialysis develops symptoms suggesting vascular steal syndrome in the access limb, with signs of ischemia. The team wants to minimize radiation exposure while still following the appropriateness criteria. Among the listed options, which procedure is considered appropriate or potentially appropriate and does not inherently require ionizing radiation?","In suspected vascular steal syndrome (upper or lower extremity), suggested by cardiac failure or ischemic symptoms (treatment and procedures), the procedure that is appropriate or potentially appropriate and does not inherently require ionizing radiation is:
- Surgical consultation: Usually Appropriate
(Other potentially appropriate options—continued hemodialysis access use with surveillance, fluoroscopy fistulography with intervention, and placement of a new tunneled dialysis catheter—either involve or may involve ionizing radiation, particularly fluoroscopy fistulography.)","The appropriate choice is **duplex Doppler ultrasound of the dialysis access and limb arteries**, as it is considered appropriate/potentially appropriate for suspected steal syndrome and does **not** inherently use ionizing radiation.",Duplex Doppler ultrasound of the access limb is the appropriate/potentially appropriate procedure that does not inherently require ionizing radiation.,"For suspected vascular steal syndrome with ischemic symptoms, the ACR Appropriateness Criteria list the following as appropriate or potentially appropriate:

- **US duplex Doppler hemodialysis access area of interest (Variant 11 – initial imaging)** – **Usually Appropriate** and **does not use ionizing radiation**.

All of the other procedures rated appropriate or potentially appropriate for this scenario (fluoroscopy fistulography, CTA/CTV, etc.) require ionizing radiation. Therefore, **US duplex Doppler of the hemodialysis access** is the procedure that both aligns with the criteria and avoids inherent radiation exposure."
"For a patient with malignant hilar biliary obstruction, how is a percutaneous internal/external biliary catheter rated as an initial therapeutic procedure?","For initial therapy of malignant hilar biliary obstruction, a percutaneous internal/external biliary catheter is rated as Usually Appropriate.","For malignant hilar biliary obstruction, placement of a percutaneous internal/external biliary drainage catheter as the **initial therapeutic procedure** is typically reported with:

**CPT 47511** – “Percutaneous transhepatic biliary drainage with internal and external catheter, initial.”","For malignant hilar biliary obstruction, a percutaneous internal/external biliary catheter is rated as **“Usually Appropriate”** as an initial therapeutic procedure.","For malignant hilar biliary obstruction, a **percutaneous internal/external biliary catheter is rated “Usually Appropriate”** as an initial therapeutic procedure (ACR Appropriateness Criteria, Variant 7)."
"In a patient with malignant hilar biliary obstruction (such as a Klatskin tumor) who needs an initial therapeutic procedure, which of the listed options are considered appropriate or potentially appropriate according to their ratings?","For initial therapy of malignant hilar biliary obstruction from malignant etiology, the procedures that are appropriate or potentially appropriate are:
- Percutaneous internal/external biliary catheter (Usually Appropriate)
- Endoscopic internal biliary catheter (removable plastic stent) (May Be Appropriate)
- Surgery (May Be Appropriate)
- Permanent biliary metallic stent (May Be Appropriate)
- Removable biliary covered stent (May Be Appropriate)","For an initial therapeutic procedure in malignant hilar biliary obstruction (e.g., Klatskin tumor), the options generally rated as **appropriate or potentially appropriate** (depending on exact anatomy, resectability, and expertise) are:

- **Endoscopic biliary drainage (EBD)** with:
  - Unilateral stent placement (in selected cases)
  - Bilateral stent placement (often preferred for higher Bismuth types)
  - Plastic or self‑expanding metal stents (SEMS), chosen based on expected survival and surgical plan

- **Percutaneous transhepatic biliary drainage (PTBD)**:
  - As primary therapy when endoscopic access is difficult or fails
  - As adjunct to incomplete endoscopic drainage

- **Combined endoscopic–percutaneous drainage**:
  - In complex, high‑grade hilar strictures where single‑modality drainage is inadequate

- **Endoscopic ultrasound–guided biliary drainage (EUS‑BD)**:
  - In centers with expertise, particularly after failed ERCP or when ERCP is not feasible

In contrast, options such as routine preoperative drainage of all resectable low‑grade hilar tumors, or procedures that do not achieve adequate drainage of functional liver volume, are generally rated as **inappropriate**.","For malignant hilar biliary obstruction (e.g., Klatskin tumor), the options rated as appropriate or potentially appropriate for the *initial* therapeutic procedure are:

- Percutaneous internal/external biliary catheter – **Usually Appropriate**
- Endoscopic internal biliary catheter (removable plastic stent) – **May Be Appropriate**
- Surgery – **May Be Appropriate**
- Permanent biliary metallic stent – **May Be Appropriate**
- Removable biliary covered stent – **May Be Appropriate**

Medical management only and endoscopic US-guided biliary drainage (EUS-BD) are not considered appropriate in this setting.","For malignant hilar biliary obstruction (e.g., Klatskin tumor), as an initial therapeutic procedure the following options are rated appropriate or potentially appropriate:

- **Percutaneous internal/external biliary catheter – Usually Appropriate**
- **Endoscopic internal biliary catheter (removable plastic stent) – May Be Appropriate**
- **Surgery – May Be Appropriate**
- **Permanent biliary metallic stent – May Be Appropriate**
- **Removable biliary covered stent – May Be Appropriate**

The option rated not appropriate in this setting is **endoscopic US-guided biliary drainage (EUS-BD) – Usually Not Appropriate**."
"For a patient with abnormal skin changes at a hemodialysis access cannulation site who needs initial imaging to guide interventional radiologic therapy, which imaging procedures from the list are NOT considered appropriate?","For initial imaging of abnormal skin changes at an upper or lower extremity hemodialysis access cannulation site, the procedures that are NOT appropriate are:
- MRA extremity area of interest without and with IV contrast (Usually Not Appropriate)
- MRA extremity area of interest without IV contrast (Usually Not Appropriate)
- MRV extremity area of interest without and with IV contrast (Usually Not Appropriate)
- MRV extremity area of interest without IV contrast (Usually Not Appropriate)
- CTA extremity area of interest with IV contrast (Usually Not Appropriate)
- CTV extremity area of interest with IV contrast (Usually Not Appropriate)","Imaging procedures that are **not** considered appropriate as the *initial* study in this setting include:

- **CT angiography** of the extremity/access  
- **MR angiography** of the extremity/access  
- **Non–access-focused CT or MRI** of the limb  
- **Nuclear medicine perfusion or flow studies** of the limb/access  

Initial imaging to guide interventional radiologic therapy for abnormal skin changes at a hemodialysis access site should be with **duplex ultrasound** and/or **catheter-based contrast fistulography/venography**; the cross-sectional and nuclear techniques above are not appropriate as first-line studies.","For abnormal skin changes at a hemodialysis access cannulation site (initial imaging), the following procedures are NOT considered appropriate:

- MRA extremity (with and without IV contrast)  
- MRA extremity (without IV contrast)  
- MRV extremity (with and without IV contrast)  
- MRV extremity (without IV contrast)  
- CTA extremity with IV contrast  
- CTV extremity with IV contrast","For abnormal skin changes at a hemodialysis access cannulation site (initial imaging to guide interventional radiologic therapy; Variant 9), the following listed imaging procedures are **NOT** considered appropriate:

- MRA extremity, area of interest, without and with IV contrast – Usually Not Appropriate  
- MRA extremity, area of interest, without IV contrast – Usually Not Appropriate  
- MRV extremity, area of interest, without and with IV contrast – Usually Not Appropriate  
- MRV extremity, area of interest, without IV contrast – Usually Not Appropriate  
- CTA extremity, area of interest, with IV contrast – Usually Not Appropriate  
- CTV extremity, area of interest, with IV contrast – Usually Not Appropriate

The only procedures considered appropriate or potentially appropriate in this scenario are **US duplex Doppler of the hemodialysis access (Usually Appropriate)** and **fluoroscopy fistulography of the access (May Be Appropriate)**."
"In evaluating abnormal skin changes at a hemodialysis access cannulation site, how do US duplex Doppler of the access and fluoroscopy fistulography of the access compare in terms of appropriateness for initial imaging?","For initial imaging of abnormal skin changes at a hemodialysis access cannulation site:
- US duplex Doppler hemodialysis access area of interest is rated as Usually Appropriate.
- Fluoroscopy fistulography hemodialysis access area of interest is rated as May Be Appropriate.","For **initial imaging** of abnormal skin changes at a hemodialysis access cannulation site:

- **US duplex Doppler of the access** is **usually appropriate as the first-line study**.  
  - Noninvasive, no contrast, can assess flow, stenosis, thrombosis, pseudoaneurysm, hematoma, and surrounding soft tissues.

- **Fluoroscopy fistulography of the access** is generally **not the first choice for initial evaluation** of skin changes alone.  
  - It is more invasive, requires contrast, and is typically reserved for:
    - Problem-solving when ultrasound is nondiagnostic or equivocal
    - Planning and performing endovascular interventions (e.g., angioplasty, stenting).

So, **US duplex Doppler is preferred as the initial imaging modality**, with fistulography used second-line or when intervention is anticipated.","For abnormal skin changes at a hemodialysis access cannulation site, duplex Doppler ultrasound of the access is **usually appropriate and preferred as the initial imaging** study. 

Fluoroscopy fistulography of the access is only **“may be appropriate”** in this setting and is not the first-line choice for initial imaging.","For initial imaging of abnormal skin changes at a hemodialysis access cannulation site:

- **US duplex Doppler of the hemodialysis access** is rated **“Usually Appropriate”** and is the preferred initial imaging modality.
- **Fluoroscopy fistulography of the hemodialysis access** is rated **“May Be Appropriate”** and is considered a secondary or selectively used option, rather than first-line.

So, duplex ultrasound is generally favored as the primary initial study, with fistulography reserved for selected cases where additional anatomic/angiographic detail is needed or when planning an intervention."
"A case involves a patient with marked thinning and ulceration over an upper extremity hemodialysis fistula, and you want an initial imaging study that avoids ionizing radiation exposure. Based on the ratings, which low- or no-radiation imaging option is considered most appropriate for guiding interventional radiologic therapy?","For initial imaging of abnormal skin changes at a hemodialysis access cannulation site while avoiding ionizing radiation, US duplex Doppler hemodialysis access area of interest is the most appropriate option, rated as Usually Appropriate. The available MR-based options (MRA and MRV, with or without contrast) are all rated as Usually Not Appropriate.",Duplex Doppler **ultrasound** of the hemodialysis access is the most appropriate low-/no-radiation imaging option to guide interventional radiologic therapy.,US duplex Doppler of the hemodialysis access is the most appropriate low-/no-radiation initial imaging study to guide interventional radiologic therapy in this setting.,"For this patient, the most appropriate low-/no-radiation initial imaging study is **US duplex Doppler of the hemodialysis access**, which is rated **“Usually Appropriate”** for guiding interventional radiologic therapy in the setting of abnormal skin changes over a hemodialysis access cannulation site."
"For an elderly patient over 60 with a positive PPD, abnormal chest radiograph, and bulky noncalcified mediastinal adenopathy on CT without pulmonary nodules, how is endoscopic/bronchoscopic biopsy rated for this scenario?",Endoscopic/bronchoscopic biopsy is rated as Usually Appropriate for this scenario.,"In that scenario (bulky, noncalcified mediastinal adenopathy on CT, no pulmonary nodules), endoscopic/bronchoscopic biopsy of mediastinal lymph nodes (e.g., EBUS‑TBNA or EUS‑FNA) is considered **a highly appropriate / first‑line diagnostic test**—typically rated in the **“usually appropriate” (highest) category** in appropriateness criteria for mediastinal lymph node evaluation.",Endoscopic/bronchoscopic biopsy is rated 8 (usually appropriate) for this scenario.,"In this scenario (elderly patient >60 years with positive PPD, abnormal chest radiograph, bulky noncalcified mediastinal adenopathy on CT, and no pulmonary nodules), **endoscopic/bronchoscopic biopsy is rated 8**, which falls in the **“Usually Appropriate”** category."
"In an elderly patient with a positive tuberculin test, abnormal chest x-ray, and bulky noncalcified mediastinal adenopathy on CT without pulmonary nodules, which procedures are considered appropriate or potentially appropriate (ie, Usually Appropriate or May Be Appropriate) for tissue diagnosis or management?","For this scenario, the procedures that are appropriate or potentially appropriate are:
- Endoscopic/bronchoscopic biopsy: Usually Appropriate
- Percutaneous mediastinal biopsy: May Be Appropriate
- Surgical mediastinal biopsy/resection: May Be Appropriate","For an elderly patient with positive tuberculin test, abnormal CXR, and bulky noncalcified mediastinal adenopathy on CT (no pulmonary nodules), the following procedures are considered **appropriate or potentially appropriate** for tissue diagnosis/management (per ACCP/ACR-type appropriateness criteria):

**Usually Appropriate (first-line / preferred):**
1. **Endobronchial ultrasound–guided transbronchial needle aspiration (EBUS-TBNA)** of mediastinal lymph nodes  
2. **Endoscopic ultrasound–guided fine-needle aspiration (EUS-FNA)** of mediastinal lymph nodes (if accessible)  
3. **Mediastinoscopy with lymph node biopsy** (especially if EBUS/EUS not available, non-diagnostic, or nodes in accessible stations)

**May Be Appropriate (potentially appropriate in selected cases):**
4. **CT-guided percutaneous needle biopsy** of mediastinal lymph nodes (if safely accessible)  
5. **Video-assisted thoracoscopic surgery (VATS) lymph node biopsy** (if less invasive approaches are non-diagnostic or not feasible)  

Procedures focused on lung parenchyma (e.g., transbronchial lung biopsy of normal-appearing lung, CT-guided lung nodule biopsy) are generally **not** appropriate here given the absence of pulmonary nodules and the primary abnormality being mediastinal adenopathy.","For this elderly patient (Variant 9 scenario), the following are considered:

Usually Appropriate:
- Endoscopic/bronchoscopic biopsy

May Be Appropriate:
- Percutaneous mediastinal biopsy (if bronchoscopic biopsy fails and a safe percutaneous route exists)
- Surgical mediastinal biopsy/resection (depending on local expertise and accessibility of nodes by nonsurgical approaches)

Follow-up imaging only and conservative management are not considered appropriate.","For this scenario (elderly patient >60 with positive PPD, abnormal chest radiograph, bulky noncalcified mediastinal adenopathy on CT, no pulmonary nodules), the ACR variant lists the following procedures as appropriate or potentially appropriate:

1. **Endoscopic/bronchoscopic biopsy – Rating 8 (Usually Appropriate)**  
   • Considered the primary/first-line procedure for tissue diagnosis.

2. **Percutaneous mediastinal biopsy – Rating 5 (May Be Appropriate)**  
   • Consider if bronchoscopic biopsy fails and if the mediastinal lymph nodes can be safely accessed percutaneously.

3. **Surgical mediastinal biopsy/resection – Rating 4 (May Be Appropriate)**  
   • Might be appropriate depending on local expertise and if nonsurgical approaches (bronchoscopic or percutaneous) are not feasible or have been nondiagnostic.

The following are **not** considered appropriate:  
• Follow-up imaging only – Rating 2 (Usually not appropriate)  
• Conservative management (do nothing) – Rating 1 (Usually not appropriate)."
"A patient presents 5 weeks after acute pancreatitis with abdominal pain radiating to the back. Imaging shows a walled-off pancreatic collection in the body of the pancreas that indents the stomach and affects the gastric outlet, with a patent pancreatic duct and a 3-cm percutaneous window. Which management option is considered NOT appropriate in this setting?","In this scenario, conservative management only is rated as Usually Not Appropriate.","The **not appropriate** management option is:

**Percutaneous drainage** of the walled-off pancreatic collection.

In this setting (mature walled-off necrosis, symptomatic with gastric outlet obstruction, patent duct, and a good 3‑cm window to the stomach), the preferred approaches are **endoscopic transmural drainage** (e.g., cystogastrostomy) or **surgical internal drainage**, not percutaneous drainage.",The NOT appropriate option is **percutaneous needle aspiration** of the collection for therapeutic purposes.,"In this setting, **conservative management only** is considered **Usually Not Appropriate** and thus is the management option that is NOT appropriate.

Appropriateness ratings for this scenario:
- Endoscopic cystgastrostomy – Usually Appropriate
- Percutaneous catheter drainage only – May Be Appropriate
- Percutaneous needle aspiration – May Be Appropriate
- Surgical cystenterostomy – May Be Appropriate
- **Conservative management only – Usually Not Appropriate (NOT appropriate option)**"
"For an elderly patient with positive PPD and bulky noncalcified mediastinal adenopathy on CT, no pulmonary nodules, and an abnormal chest radiograph, how do endoscopic/bronchoscopic biopsy and percutaneous mediastinal biopsy compare in terms of appropriateness?","In this mediastinal adenopathy scenario, endoscopic/bronchoscopic biopsy is rated as Usually Appropriate, whereas percutaneous mediastinal biopsy is rated as May Be Appropriate.","In this setting, endoscopic/bronchoscopic biopsy is generally preferred and more appropriate than percutaneous mediastinal biopsy.

Reasoning:

- **Endoscopic/bronchoscopic (e.g., EBUS-TBNA, EUS-FNA, or mediastinoscopy)**  
  - Specifically designed to sample mediastinal lymph nodes.  
  - High diagnostic yield for bulky noncalcified mediastinal adenopathy.  
  - Allows direct visualization of airways and nodes, multiple samples, and concurrent evaluation for other pathology (e.g., endobronchial lesions).  
  - Lower risk of pneumothorax and major vascular injury compared with many percutaneous approaches.  
  - Widely accepted as first-line for mediastinal adenopathy of unclear cause (malignancy vs. granulomatous disease such as TB or sarcoidosis).

- **Percutaneous mediastinal biopsy (CT-guided transthoracic needle biopsy)**  
  - Typically reserved when endoscopic access is not feasible (e.g., very anterior or paravertebral nodes not reachable by EBUS/EUS) or when prior endoscopic sampling is nondiagnostic.  
  - Higher risk of pneumothorax, bleeding, and injury to mediastinal structures, especially in elderly patients.  
  - Technically more challenging for some mediastinal locations.

Given an elderly patient with bulky mediastinal adenopathy and abnormal CXR but no lung nodules, an **endoscopic/bronchoscopic approach (EBUS/EUS or mediastinoscopy) is the more appropriate initial diagnostic procedure**, with percutaneous biopsy as a secondary option if endoscopic methods are not possible or are nondiagnostic.","Endoscopic/bronchoscopic biopsy is considered usually appropriate (rating 8) and is preferred as the initial diagnostic approach.

Percutaneous mediastinal biopsy is only “may be appropriate” (rating 5) and is recommended mainly if bronchoscopic/endoscopic biopsy fails and the nodes can be safely accessed percutaneously.","For this scenario (elderly patient >60 with positive PPD, abnormal CXR, bulky noncalcified mediastinal adenopathy on CT, no pulmonary nodules):

- **Endoscopic/bronchoscopic biopsy**: Rated **8 – “Usually Appropriate.”** This is the preferred first-line diagnostic approach.
- **Percutaneous mediastinal biopsy**: Rated **5 – “May Be Appropriate.”** It is considered a secondary option, typically **if bronchoscopic biopsy fails** and if the nodes can be safely accessed percutaneously.

So, endoscopic/bronchoscopic biopsy is considered clearly more appropriate than percutaneous mediastinal biopsy in this setting."
"You are considering options that avoid additional ionizing radiation for a patient 5 weeks after acute pancreatitis who has a walled-off pancreatic collection compressing the stomach and affecting the gastric outlet, with a patent pancreatic duct and a 3-cm percutaneous window. Among the listed interventions, which non-surgical procedure is rated as Usually Appropriate and would not itself require ionizing radiation for the therapeutic step?","Endoscopic cystgastrostomy is the non-surgical procedure rated as Usually Appropriate in this scenario and, as an endoscopic intervention, does not inherently require ionizing radiation for the therapeutic step.","The non-surgical procedure that is rated as **Usually Appropriate** and does **not** itself require ionizing radiation for the therapeutic step is:

**Endoscopic ultrasound (EUS)-guided transmural drainage of the walled-off pancreatic collection.**","The non-surgical procedure rated as Usually Appropriate that does not itself require ionizing radiation for the therapeutic step is:

**Endoscopic cystgastrostomy.**","In this scenario, the **non-surgical procedure that is rated “Usually Appropriate” and does not itself require ionizing radiation for the therapeutic step is**:

- **Endoscopic cystgastrostomy – Usually Appropriate.**

The intervention is performed endoscopically and typically uses endoscopic and/or endoscopic ultrasound guidance rather than fluoroscopy or CT, so it avoids additional ionizing radiation for the therapeutic portion of the procedure."
"For a middle-aged patient with a 1.5-cm smooth lung nodule incidentally found on a negative CT pulmonary angiogram, with no adenopathy but a 70 pack/year smoking history and significant COPD, how is percutaneous lung biopsy rated for this indication?",Percutaneous lung biopsy is rated as Usually Appropriate for this scenario.,"For this scenario, percutaneous lung biopsy is considered **“Usually Appropriate”** (highly appropriate).

Rationale in guideline terms:
- Solitary, solid pulmonary nodule >8 mm (here 15 mm)
- High-risk patient (heavy smoker, COPD)
- No clear benign etiology on CT
- Tissue diagnosis needed to guide management

In the ACR Appropriateness Criteria for “Incidentally Detected Pulmonary Nodules,” CT-guided percutaneous transthoracic needle biopsy for a solid nodule ≥8 mm in a high-risk patient is rated in the **highest appropriateness category**.",Percutaneous lung biopsy is rated 8 (“usually appropriate”) for this indication.,"For this indication, **percutaneous lung biopsy is rated 8**, which falls in the **“Usually Appropriate”** category."
"In a middle-aged patient with a 1.5-cm smooth incidental lung nodule on CT pulmonary angiogram, no adenopathy, but a 70 pack/year smoking history and significant COPD, which procedures are considered appropriate (including both Usually Appropriate and May Be Appropriate) management options?","For this scenario, the procedures considered appropriate are:
- Percutaneous lung biopsy (Usually Appropriate)
- FDG-PET/CT whole body (Usually Appropriate)
- Surgical lung biopsy/resection (May Be Appropriate)","For a **middle‑aged, very high‑risk smoker (70 pack‑years, COPD)** with a **1.5‑cm smooth solid incidental lung nodule** and **no adenopathy** on CT pulmonary angiogram, the following are considered appropriate management options (from ACR/ACCP‑type guidance for solid nodules 8–20 mm in high‑risk patients):

**Usually Appropriate**
- **Short‑interval CT chest follow‑up** (e.g., at about 3 months, then continued surveillance if stable)
- **PET‑CT** to further characterize the nodule (given size ≥8 mm and high pretest risk)
- **Tissue diagnosis** when malignancy risk is judged moderate–high:
  - **CT‑guided transthoracic needle biopsy** (if technically feasible)
  - **Bronchoscopic biopsy** (including navigational bronchoscopy if peripheral)
- **Surgical resection** (e.g., VATS wedge/segmentectomy) if the patient is an acceptable operative candidate and malignancy probability is high enough to justify proceeding directly to surgery

**May Be Appropriate**
- **Longer‑interval CT surveillance alone** (e.g., at 6–12 months and then 18–24 months) if, after formal risk assessment, the estimated malignancy risk is not clearly high and the patient/clinician prefer noninvasive management
- **Advanced bronchoscopic techniques** (e.g., electromagnetic navigation bronchoscopy) for biopsy in centers with expertise, when percutaneous biopsy is higher risk or less feasible

In this risk profile, doing **nothing** or **very delayed imaging only** would not be considered appropriate.","For this middle-aged heavy smoker with COPD and an incidental 1.5‑cm smooth lung nodule (Variant 2), the ACR ratings are:

Usually Appropriate (ratings 7–9):
- Percutaneous lung biopsy (rating 8)  
- FDG-PET/CT whole body (rating 8)

May Be Appropriate (ratings 4–6):
- Surgical lung biopsy/resection (rating 5)

Usually Not Appropriate:
- Follow-up imaging only (rating 2)  
- Conservative management / do nothing (rating 1)

So the appropriate management options (Usually Appropriate + May Be Appropriate) are:
- Percutaneous lung biopsy  
- FDG-PET/CT whole body  
- Surgical lung biopsy/resection","For this patient scenario, the ACR Appropriateness Criteria consider the following procedures appropriate (ratings ≥5):

- **Percutaneous lung biopsy – 8 (Usually Appropriate)**
- **FDG-PET/CT whole body – 8 (Usually Appropriate)**
- **Surgical lung biopsy/resection – 5 (May Be Appropriate)**

“Follow-up imaging only” (2) and “conservative management” (1) are not considered appropriate in this setting."
"For the initial therapeutic management of a patient with malignant hilar biliary obstruction (such as a Klatskin tumor), which listed options are NOT considered appropriate (ie, rated Usually Not Appropriate)?","For initial therapy of malignant hilar biliary obstruction, the procedures rated as Usually Not Appropriate are:
- Medical management only
- Endoscopic US-guided biliary drainage (EUS-BD)","For initial therapeutic management of malignant hilar biliary obstruction (e.g., Klatskin tumor), the following are **Usually Not Appropriate**:

- **Percutaneous transhepatic biliary drainage (PTBD) without intent to drain the future liver remnant** (i.e., non-targeted or unnecessary bilateral drainage in unresectable disease).  
- **Endoscopic placement of uncovered self-expanding metal stents (SEMS) when surgery is planned** (because they may interfere with future resection).  
- **Routine bilateral stenting in all patients** (when unilateral drainage of the future liver remnant is sufficient).  
- **Primary surgical resection without prior biliary drainage** in patients with significant jaundice or cholangitis.  
- **Palliative surgical bypass (hepaticojejunostomy or similar)** as an initial step in clearly unresectable disease, where endoscopic or percutaneous drainage is feasible.  

In most guideline/appropriateness criteria, initial management should favor **targeted drainage of the future liver remnant** (via ERCP or PTBD depending on anatomy and expertise) and avoid non-selective, potentially complicating interventions such as non-targeted PTBD, unnecessary bilateral stenting, or early metal stent placement in potentially resectable cases.","For malignant hilar biliary obstruction (Klatskin tumor), the following options are rated “Usually Not Appropriate” for initial therapeutic management:

- Medical management only  
- Endoscopic US–guided biliary drainage (EUS‑BD)","For initial therapeutic management of malignant hilar biliary obstruction (eg, Klatskin tumor), the options rated **Usually Not Appropriate** are:

- **Medical management only**  
- **Endoscopic US–guided biliary drainage (EUS‑BD)**

All other listed options (percutaneous internal/external biliary catheter, endoscopic internal biliary catheter with removable plastic stent, surgery, permanent metallic stent, removable covered metallic stent) are rated as May Be Appropriate or Usually Appropriate for this indication."
"In a patient with malignant hilar biliary obstruction requiring an initial therapeutic procedure, how does the appropriateness of a percutaneous internal/external biliary catheter compare with that of an endoscopic internal biliary catheter using a removable plastic stent?","For initial therapy of malignant hilar biliary obstruction, a percutaneous internal/external biliary catheter is rated as Usually Appropriate, whereas an endoscopic internal biliary catheter with a removable plastic stent is rated as May Be Appropriate.","For an initial therapeutic procedure in malignant hilar biliary obstruction:

- **Percutaneous internal/external biliary catheter** is generally considered **more appropriate** than  
- **Endoscopic internal biliary catheter with a removable plastic stent**.

This is because percutaneous drainage allows more controlled, targeted decompression of specific hepatic segments in complex hilar strictures (especially higher Bismuth types), often with better technical success and drainage of adequate liver volume. Endoscopic plastic stenting is less favored as the initial approach in high hilar lesions due to lower success in selective segmental drainage and higher risk of incomplete drainage.","For malignant hilar biliary obstruction as an initial therapeutic procedure:

- A **percutaneous internal/external biliary catheter** is **usually appropriate**.
- An **endoscopic internal biliary catheter with a removable plastic stent** is only **may be appropriate**.

So, percutaneous internal/external drainage is generally preferred and considered more appropriate than endoscopic plastic stenting in this specific setting.","For initial therapeutic management of malignant hilar biliary obstruction (eg, Klatskin tumor):

- **Percutaneous internal/external biliary catheter** is rated **Usually Appropriate**.
- **Endoscopic internal biliary catheter with a removable plastic stent** is rated **May Be Appropriate**.

So, percutaneous internal/external drainage is considered more appropriate (preferred) than endoscopic plastic stenting in this specific setting, based on the ACR Appropriateness Criteria."
"You are concerned about radiation exposure in a 50-year-old heavy smoker with significant COPD who has an incidental 1.5-cm smooth lung nodule on CT pulmonary angiogram with no adenopathy. Among the listed management options for this nodule, which ones do NOT involve additional ionizing radiation exposure beyond what has already been performed?","Among the listed options for this lung nodule scenario, the procedures that do not inherently involve additional ionizing radiation are:
- Surgical lung biopsy/resection (May Be Appropriate)
- Conservative management (do nothing) (Usually Not Appropriate)

Percutaneous lung biopsy and FDG-PET/CT whole body both involve additional ionizing radiation, and follow-up imaging only would also entail further radiation exposure.","Options that do **not** involve additional ionizing radiation are:

- **PET/MRI** (if specified as MRI-based, not PET/CT)  
- **MRI of the chest**  
- **Bronchoscopy** (including navigational or endobronchial ultrasound–guided)  
- **Surgical procedures** (e.g., VATS wedge resection, lobectomy)  
- **Clinical follow-up without imaging**  

Any option involving CT (including low-dose CT), PET/CT, or plain chest radiography would add further ionizing radiation.","The options listed for this patient (Variant 2) are:

- Percutaneous lung biopsy  
- FDG-PET/CT whole body  
- Surgical lung biopsy/resection  
- Follow-up imaging only  
- Conservative management (do nothing)

Procedures that do NOT involve additional ionizing radiation:

- Surgical lung biopsy/resection  
- Conservative management (do nothing)

(“Follow-up imaging only” would involve additional CT or radiography, and both percutaneous lung biopsy and FDG-PET/CT use imaging with ionizing radiation.)","For this 50-year-old heavy smoker with COPD and an incidental 1.5‑cm smooth lung nodule on CT pulmonary angiogram (Variant 2 of the ACR Radiologic Management of Thoracic Nodules and Masses), the listed management options and whether they add ionizing radiation are:

- **Percutaneous lung biopsy (rating 8)** – Uses CT or fluoroscopic guidance and therefore **does involve additional ionizing radiation**.
- **FDG-PET/CT whole body (rating 8)** – Involves CT as part of PET/CT and therefore **does involve additional ionizing radiation**.
- **Surgical lung biopsy/resection (rating 5)** – **Does not inherently require additional ionizing radiation**; the surgery itself uses no ionizing radiation (beyond any separate imaging that might be ordered perioperatively).
- **Follow-up imaging only (rating 2)** – Would typically be done with chest CT or radiography and thus **does involve additional ionizing radiation**.
- **Conservative management (do nothing) (rating 1)** – **Does not involve any additional ionizing radiation**.

Therefore, among the listed options, the ones that do **not** involve additional ionizing radiation exposure beyond what has already been performed are:

- **Surgical lung biopsy/resection**  
- **Conservative management (do nothing)**"
"For an elderly heavy smoker whose low-dose screening CT shows a 2-cm lingular pulmonary nodule with 2-cm pretracheal, subcarinal, and left perihilar adenopathy, how is an endoscopic/bronchoscopic mediastinal biopsy rated for appropriateness?",Endoscopic/bronchoscopic mediastinal biopsy is rated as Usually Appropriate.,"In that scenario, an endoscopic/bronchoscopic mediastinal biopsy (e.g., EBUS-TBNA ± EUS) is rated **“usually appropriate” (high appropriateness)** for initial tissue diagnosis and mediastinal staging.",It is rated as **8 – “usually appropriate.”**,"For this elderly heavy smoker with a 2‑cm lingular pulmonary nodule and 2‑cm mediastinal and perihilar adenopathy (Variant 10), an **endoscopic/bronchoscopic mediastinal biopsy** is rated **8 (Usually Appropriate)** in the ACR Appropriateness Criteria for Radiologic Management of Thoracic Nodules and Masses."
"In an elderly (>60 years) heavy smoker with a 2-cm lingular pulmonary nodule on LDCT and associated mediastinal and left perihilar adenopathy up to 2 cm, which procedures are considered appropriate (Usually Appropriate or May Be Appropriate) for further evaluation or management?","The appropriate procedures (Usually Appropriate or May Be Appropriate) are:
- Endoscopic/bronchoscopic mediastinal biopsy (Usually Appropriate)
- FDG-PET/CT whole body (Usually Appropriate)
- Percutaneous lung biopsy (Usually Appropriate)
- Percutaneous mediastinal biopsy (May Be Appropriate)",,I do not know.,"For this scenario (elderly >60-year heavy smoker, LDCT showing a 2‑cm lingular pulmonary nodule with mediastinal and left perihilar adenopathy up to 2 cm; ACR Variant 10), the ACR Appropriateness Criteria ratings are:

Usually Appropriate (7–9):
- **Endoscopic/bronchoscopic mediastinal biopsy** – Rating 8  
- **FDG-PET/CT whole body** – Rating 8  
- **Percutaneous lung biopsy** – Rating 7

May Be Appropriate (4–6):
- **Percutaneous mediastinal biopsy** – Rating 6

Usually Not Appropriate (for completeness):
- **Surgical pulmonary nodule biopsy/resection** – Rating 3  
- **Follow-up imaging only** – Rating 2  
- **Conservative management (do nothing)** – Rating 1

Thus, the procedures considered appropriate (Usually Appropriate or May Be Appropriate) for further evaluation/management are:
- Endoscopic/bronchoscopic mediastinal biopsy  
- FDG-PET/CT whole body  
- Percutaneous lung biopsy  
- Percutaneous mediastinal biopsy"
"For a cirrhotic patient with hepatocellular carcinoma that is solitary or multifocal with vascular invasion, which treatment options are specifically rated as NOT appropriate (Usually Not Appropriate)?","The procedures rated as Usually Not Appropriate are:
- Percutaneous ablation liver
- Surgical liver resection
- Liver transplantation","For a cirrhotic patient with HCC that is solitary or multifocal **with vascular invasion**, the following are specifically rated **“Usually Not Appropriate”** as treatment options:

- **Surgical resection**  
- **Liver transplantation**  
- **Percutaneous ablation** (e.g., RFA, MWA, PEI)  
- **Transarterial chemoembolization (TACE)** (conventional or drug-eluting bead)  

These are generally contraindicated or not recommended once there is macrovascular invasion.","For a cirrhotic patient with hepatocellular carcinoma that is solitary or multifocal with vascular invasion, the ACR Appropriateness Criteria rate the following as **Usually Not Appropriate**:

- **Liver transplantation**  
- **Percutaneous ablation alone** (e.g., RFA or MWA as sole therapy)  

Other locoregional or systemic therapies may be considered, but these two are specifically rated as not appropriate in the setting of vascular invasion.","For a cirrhotic patient with hepatocellular carcinoma that is solitary or multifocal with vascular invasion (ACR Variant 4), the following treatment options are specifically rated **Usually Not Appropriate**:

- **Percutaneous ablation liver**  
- **Surgical liver resection**  
- **Liver transplantation**"
"In an elderly smoker with a 2-cm lingular pulmonary nodule and mediastinal adenopathy on LDCT, how do percutaneous lung biopsy and percutaneous mediastinal biopsy compare in terms of appropriateness for further workup?","For this scenario, percutaneous lung biopsy is rated as Usually Appropriate, whereas percutaneous mediastinal biopsy is rated as May Be Appropriate.","In this setting (elderly smoker, 2‑cm lingular nodule, mediastinal adenopathy on LDCT), percutaneous **mediastinal** biopsy is generally more appropriate as the *initial* tissue diagnosis than percutaneous lung biopsy, if technically feasible.

Key points:

- **Goal:** You need both diagnosis and staging. Enlarged mediastinal nodes may represent N2/N3 disease, which upstages to at least stage III and often changes management from surgical to nonsurgical approaches.
- **Biopsying mediastinal nodes first**:
  - Directly answers the critical staging question (is there mediastinal involvement?).
  - If positive for malignancy, you have both diagnosis and stage in one step, often obviating the need for percutaneous lung biopsy.
  - Is consistent with guideline-based practice, which prioritizes sampling the most advanced (highest-stage) site of disease that is safely accessible.

- **Percutaneous lung biopsy**:
  - Provides diagnosis of the primary lesion but does not stage the mediastinum.
  - If the mediastinal nodes remain unbiopsied, you may still need an additional procedure (EBUS, mediastinoscopy, or percutaneous nodal biopsy) for staging.
  - Has higher risk of pneumothorax than mediastinal node biopsy in many anatomic situations.

- **Technique choice**:
  - In practice, endobronchial ultrasound–guided transbronchial needle aspiration (EBUS‑TBNA) is usually preferred over percutaneous mediastinal biopsy when available, but among *percutaneous* options, targeting the mediastinal adenopathy first is more appropriate for comprehensive workup.

So, for further workup, percutaneous **mediastinal** biopsy is preferred over percutaneous lung biopsy as the initial procedure, provided it is technically and safely achievable.","For this scenario (elderly heavy smoker, 2‑cm lingular nodule on LDCT with mediastinal adenopathy):

- Percutaneous lung biopsy is rated as more appropriate (rating 7: “usually appropriate”).
- Percutaneous mediastinal biopsy is somewhat less appropriate (rating 6: “may be appropriate”) and is more dependent on node accessibility and local expertise.

So, percutaneous lung biopsy is generally preferred as the next percutaneous tissue-sampling step, while percutaneous mediastinal biopsy is a secondary option when technically favorable or based on institutional expertise.","In this scenario (elderly smoker, 2‑cm lingular nodule with mediastinal adenopathy on LDCT – ACR Variant 10):

- **Percutaneous lung biopsy** is rated **7 – Usually Appropriate**.
- **Percutaneous mediastinal biopsy** is rated **6 – May Be Appropriate**.

So, percutaneous lung biopsy is considered more appropriate than percutaneous mediastinal biopsy for further workup, though both are acceptable options, with lung biopsy having the higher appropriateness rating."
"You are concerned about radiation exposure in an elderly heavy smoker who already had a low-dose screening CT and is found to have a 2-cm lingular pulmonary nodule with mediastinal adenopathy. Among the recommended next-step procedures, which option involves additional ionizing radiation, and how is it rated for appropriateness?",FDG-PET/CT whole body involves additional ionizing radiation and is rated as Usually Appropriate in this scenario.,"Among the usual next-step options (e.g., PET/CT, bronchoscopy with EBUS, transthoracic needle biopsy, or surgical biopsy), the one that clearly adds **additional ionizing radiation** is:

- **FDG PET/CT scan** – this uses both CT and a radioactive tracer.

On the ACR Appropriateness Criteria for a 2‑cm pulmonary nodule with mediastinal adenopathy in a high‑risk patient, **FDG PET/CT is rated “Usually Appropriate” (highest appropriateness category)** despite the added radiation, because it provides critical staging and characterization information.","Among the recommended next-step procedures, FDG-PET/CT whole body involves additional ionizing radiation. It is rated 8, meaning it is “usually appropriate.”","Among the recommended next-step procedures for this scenario, the option that involves **additional ionizing radiation** is:

- **FDG-PET/CT (whole body)**

In the ACR Appropriateness Criteria for an elderly heavy smoker with a 2‑cm lingular pulmonary nodule and mediastinal/perihilar adenopathy, FDG-PET/CT is rated:

- **Usually Appropriate** (appropriateness rating: **8**)

By contrast, endoscopic/bronchoscopic mediastinal biopsy and percutaneous biopsies do **not** themselves add significant ionizing radiation (apart from limited fluoroscopy/CT guidance, when used), whereas FDG-PET/CT is a dedicated imaging test that clearly adds radiation exposure but is still strongly recommended because of its staging value in this high-risk context."
"For a middle-aged patient with a 3-cm lobular mass involving the left pleura and associated rib erosion, how is percutaneous lung biopsy rated in terms of appropriateness?",Percutaneous lung biopsy is rated as Usually Appropriate for a middle-aged patient with a 3-cm lobular mass involving the left pleura and associated rib erosion.,"For that scenario, percutaneous lung biopsy is rated **“Usually Not Appropriate.”**","Percutaneous lung biopsy is rated as **8**, meaning it is **usually appropriate** for this scenario.","For a middle-aged patient with a 3‑cm lobular mass involving the left pleura and associated rib erosion, **percutaneous lung biopsy** is rated **8 – Usually Appropriate** for further workup."
"In a middle-aged patient (35–60 years) with a 3-cm lobular mass involving the left pleura and rib erosion, which procedures are considered appropriate initial management options?","For a middle-aged patient with a 3-cm lobular mass involving the left pleura and rib erosion, the procedures considered appropriate are:
- Percutaneous lung biopsy: Usually Appropriate
- FDG-PET/CT whole body: Usually Appropriate","For a 35–60-year-old with a 3‑cm lobulated pleural mass and rib erosion (suspicious for malignant chest wall/pleural tumor), appropriate *initial* management options are:

- **Image‑guided core needle biopsy** (CT‑ or US‑guided) of the mass  
- **Thoracoscopic (VATS) biopsy** of the pleural/chest wall lesion  

These are used to obtain tissue diagnosis before planning definitive treatment.","Appropriate initial management options are:

- Percutaneous lung biopsy  
- FDG-PET/CT (whole body)  

Surgical pleural biopsy/resection may be considered depending on percutaneous accessibility but is less strongly recommended as an initial step.","For a middle-aged patient (35–60 years) with a 3‑cm lobular mass involving the left pleura and associated rib erosion (ACR Variant 12), the procedures considered appropriate initial management options (rated “Usually Appropriate”) are:

- **Percutaneous lung biopsy** – rating **8 (Usually Appropriate)**
- **FDG-PET/CT (whole body)** – rating **8 (Usually Appropriate)**

Surgical pleural biopsy/resection is rated 5 (“May Be Appropriate”), and follow-up imaging only or conservative management are rated 1 (“Usually Not Appropriate”)."
"For a cirrhotic patient with bleeding from small, low-flow gastric varices, moderate ascites, a MELD score of 18, and no gastrorenal shunt on MRI, which of the listed management options are NOT considered appropriate?","In this cirrhotic patient scenario, the procedure that is NOT considered appropriate is:
- BRTO: Usually Not Appropriate","In this scenario (small, low‑flow gastric varices, MELD 18, moderate ascites, and no gastrorenal shunt), the options that are **NOT appropriate** are:

1. **BRTO (Balloon‑occluded Retrograde Transvenous Obliteration)**  
   - Requires a spontaneous gastrorenal (or gastrocaval) shunt to access the varices; absent here, so it is not feasible.

2. **Surgical shunt procedures (e.g., distal splenorenal shunt, other portosystemic shunts)**  
   - Generally inappropriate in decompensated cirrhosis with MELD ~18 and ascites due to high perioperative risk and better, less invasive alternatives.

3. **Primary TIPS solely for small, low‑flow gastric varices in this setting (if listed as a routine or first‑line option)**  
   - TIPS is reserved for uncontrolled or high‑risk bleeding; for small, low‑flow gastric varices, it is not an appropriate first‑line choice, especially with moderate ascites and MELD 18 unless there is failure of endoscopic/medical therapy.

Endoscopic therapy (e.g., cyanoacrylate injection for gastric varices) plus standard pharmacologic management would be the appropriate initial approach.","For this patient (Variant 3), the options listed as NOT appropriate are:

- Balloon-occluded retrograde transvenous obliteration (BRTO) – “Usually Not Appropriate” in this setting and the patient is ineligible due to absence of a gastrorenal shunt.","For this cirrhotic patient (Variant 3 in the ACR Radiologic Management of Gastric Varices), the management option that is explicitly NOT considered appropriate is:

- **BRTO (balloon-occluded retrograde transvenous obliteration)** – rated **“Usually Not Appropriate.”**

The following are considered acceptable (to varying degrees):
- **Endoscopic management – Usually Appropriate**
- **TIPS – Usually Appropriate**
- **Partial splenic embolization – May Be Appropriate**
- **Surgical management – May Be Appropriate**

So among the listed options, BRTO is the one not considered appropriate in this scenario."
"In a cirrhotic patient bleeding from small, low-flow gastric varices with moderate ascites, MELD 18, and no gastrorenal shunt on MRI, how do TIPS and endoscopic management compare in terms of appropriateness?","For a cirrhotic patient bleeding from small, low-flow gastric varices with moderate ascites, a MELD score of 18, and no gastrorenal shunt on MRI:
- TIPS is rated as Usually Appropriate.
- Endoscopic management is also rated as Usually Appropriate.
Thus, both TIPS and endoscopic management are considered usually appropriate options in this scenario.","For this specific scenario—small, low‑flow gastric varices, MELD 18, moderate ascites, and no gastrorenal shunt—endoscopic therapy is generally more appropriate as first‑line than TIPS.

Key points:

- **No gastrorenal shunt**: This makes BRTO or related obliteration techniques impossible, so the main options are TIPS vs endoscopic therapy (usually cyanoacrylate/glue or EUS‑guided coil/glue).
- **Small, low‑flow varices**: These are often amenable to endoscopic obliteration with good control of bleeding and lower systemic impact than TIPS.
- **MELD 18 + moderate ascites**: TIPS may help ascites but carries a nontrivial risk of post‑TIPS liver decompensation and encephalopathy at this MELD. For a non‑massive, low‑flow gastric variceal source, the risk–benefit balance often favors a less invasive, local therapy first.
- **Guideline‑consistent approach**: Current practice (AASLD/Baveno) generally reserves TIPS for:
  - Failure or recurrence after adequate endoscopic therapy, or
  - Large/high‑flow gastric varices or uncontrolled/recurrent bleeding where local therapy is inadequate.

So in this patient:
- **Endoscopic management (glue ± EUS‑guided coil/glue)** is the preferred initial definitive therapy.
- **TIPS** is appropriate as a second‑line or rescue option if endoscopic therapy fails or bleeding recurs, or if there is a concurrent strong indication (e.g., refractory ascites) and the center is comfortable with the MELD‑related risk.","For this specific scenario (small, low-flow gastric varices, moderate ascites, MELD 18, no gastrorenal shunt):

- Both **TIPS** and **endoscopic management** are considered **“usually appropriate” and equivalent alternatives**; either one alone can be chosen to manage the patient.
- **Endoscopic therapy** is technically favored by the low-flow nature of the varices, which makes sclerosant/embolization more effective.
- **TIPS** is somewhat less attractive purely on MELD grounds but gains appropriateness here because it can also help control **moderate ascites**, which is a significant additional benefit.

So, in terms of appropriateness, TIPS and endoscopic management are on the same level; choice depends on clinical priorities (ascites control, expertise/availability, and patient factors).","For a cirrhotic patient bleeding from small, low-flow gastric varices with moderate ascites, MELD 18, and no gastrorenal shunt (ACR Variant 3):

- **TIPS** is rated **“Usually Appropriate.”**
- **Endoscopic management** is also rated **“Usually Appropriate.”**

They are considered **equally appropriate initial management options**; either one may be chosen based on local expertise, patient-specific factors, and multidisciplinary judgment."
"You are trying to minimize radiation exposure when evaluating a middle-aged patient with a 3-cm lobular mass involving the left pleura and rib erosion. Among the usually appropriate options listed, which procedure involves ionizing radiation and which does not?","For a middle-aged patient with a 3-cm lobular mass involving the left pleura and rib erosion, the usually appropriate procedures are:
- Percutaneous lung biopsy: involves ionizing radiation when performed under CT or fluoroscopic guidance.
- FDG-PET/CT whole body: involves ionizing radiation from both the radiotracer and the CT component.
Neither of the usually appropriate options in this scenario is a low- or no-radiation alternative; both typically involve ionizing radiation.","The procedure that **involves ionizing radiation** is:

- **CT-guided percutaneous transthoracic needle biopsy**

The procedure that **does not involve ionizing radiation** is:

- **Ultrasound-guided percutaneous transthoracic needle biopsy**","Among the usually appropriate options for this patient:

- Involves ionizing radiation:  
  • Percutaneous lung biopsy (image-guided, typically with CT or fluoroscopy)  
  • FDG-PET/CT whole body  

- Does not involve ionizing radiation:  
  • Surgical pleural biopsy/resection","For a middle-aged patient with a 3‑cm lobular mass involving the left pleura and rib erosion (ACR Variant 12), the **usually appropriate** options are:

1. **FDG-PET/CT (whole body)** – *involves ionizing radiation*  
   - Radiation comes from both the CT component and the FDG radiotracer.

2. **MRI of the chest** – *does NOT involve ionizing radiation*  
   - Uses magnetic fields and radiofrequency pulses, not x‑rays.

So, among the usually appropriate procedures, FDG-PET/CT uses ionizing radiation, whereas chest MRI does not."
"For a cirrhotic patient bleeding from esophageal and gastric varices not amenable to endoscopic management, with a MELD score of 13, hepatic wedge pressure of 22 mmHg, and a small gastrorenal shunt on CT, how is TIPS rated for this scenario?",TIPS is rated as Usually Appropriate for this scenario.,"TIPS is **strongly recommended (Class I indication)** in this scenario.

Rationale in brief:
- Active variceal bleeding not controlled/endoscopically unmanageable is a primary indication for rescue/salvage TIPS.
- MELD 13 and wedge pressure 22 mmHg are acceptable for TIPS (no prohibitive liver dysfunction).
- Presence of a small gastrorenal shunt does not preclude TIPS; TIPS is preferred over BRTO in ongoing/uncontrolled bleeding in this setting.",TIPS is rated as “Usually Appropriate” for this scenario.,"In this scenario (cirrhotic patient with bleeding esophageal and gastric varices not amenable to endoscopic management, MELD 13, hepatic wedge pressure 22 mmHg, and a small gastrorenal shunt on CT), **TIPS is rated as “Usually Appropriate.”**"
"In a cirrhotic patient with bleeding esophageal and gastric varices not amenable to endoscopic management, MELD score 13, hepatic wedge pressure 22 mmHg, and a small gastrorenal shunt on CT, which procedures are considered appropriate or potentially appropriate treatment options?","For this scenario, the procedures that are considered appropriate or potentially appropriate are:
- TIPS: Usually Appropriate
- Partial splenic embolization: May Be Appropriate
- Surgical management: May Be Appropriate","In this setting (cirrhosis, active esophageal + gastric variceal bleeding, not endoscopically controllable, MELD 13, HVPG 22 mmHg, small gastrorenal shunt), the following are considered appropriate or potentially appropriate:

**Appropriate / First-line portal decompression:**
- **TIPS (transjugular intrahepatic portosystemic shunt)**

**Variceal embolization options (often combined with TIPS):**
- **Transvenous variceal embolization** (e.g., via TIPS or transhepatic approach)

**Shunt-based therapy for gastric varices (depending on shunt anatomy and expertise):**
- **BRTO (balloon‑occluded retrograde transvenous obliteration)** – may be technically more difficult with a small gastrorenal shunt but still potentially appropriate in experienced hands  
- **Variants such as CARTO/PARTO** (coil- or plug-assisted retrograde transvenous obliteration) – potentially appropriate alternatives to classic BRTO

In summary: TIPS (with or without variceal embolization) is clearly appropriate; BRTO/CARTO/PARTO via the small gastrorenal shunt are considered potentially appropriate options depending on technical feasibility.","For this cirrhotic patient (MELD 13) with bleeding esophageal and gastric varices not amenable to endoscopic therapy, hepatic wedge pressure 22 mmHg, and a small gastrorenal shunt:

- **Transjugular intrahepatic portosystemic shunt (TIPS)** – usually appropriate  
- **Partial splenic embolization** – may be appropriate  
- **Surgical management (e.g., surgical shunt or splenectomy)** – may be appropriate  

BRTO is considered usually not appropriate in this scenario.","For this scenario (ACR Variant 5: cirrhotic patient bleeding from esophageal and gastric varices not amenable to endoscopic management, MELD 13, wedge pressure 22 mmHg, small gastrorenal shunt on CT), the ACR Appropriateness Criteria list the following as treatment options:

- **Usually Appropriate**  
  - **TIPS**

- **May Be Appropriate (potentially appropriate)**  
  - **Partial splenic embolization**  
  - **Surgical management**

- **Usually Not Appropriate**  
  - **BRTO**

So, the procedures considered appropriate or potentially appropriate are **TIPS (usually appropriate)** and **partial splenic embolization and surgical management (may be appropriate).**"
"For a patient with a new symptomatic vertebral compression fracture seen on radiographs and no known malignancy, which imaging studies are considered NOT appropriate as the next imaging study?","For this scenario, the imaging studies that are considered NOT appropriate (Usually Not Appropriate) are:
- CT spine area of interest with IV contrast
- CT spine area of interest without and with IV contrast
- MRI spine area of interest with IV contrast
- MRI spine area of interest without and with IV contrast
- CT myelography spine area of interest
- FDG-PET/CT skull base to mid-thigh","For a new, symptomatic vertebral compression fracture on radiographs in a patient without known malignancy, the following are generally **NOT appropriate as the next imaging study** (per ACR Appropriateness Criteria):

- **FDG-PET/CT**  
- **Whole-body bone scan (skeletal scintigraphy)**  
- **Whole-body MRI** (screening-type exam rather than targeted spine MRI)  

These are typically reserved for suspected or known malignancy, infection, or systemic disease, not as the immediate next step after plain films in an otherwise low-risk patient.","For a patient with a new symptomatic vertebral compression fracture on radiographs and **no known malignancy**, the following are considered **NOT appropriate as the next imaging study**:

- **Radiation therapy (RT)–related imaging/consultation**, since there is no cancer diagnosis and the fracture is nonpathologic.
- **Systemic radionuclide therapy–related imaging**, as this is not useful for benign osteoporosis-related compression fractures.

All of the spine-focused CT, MRI, bone scan, SPECT/CT, and FDG-PET/CT techniques described are used in selected benign VCF scenarios and are not explicitly labeled as “not appropriate” as the next study in this context.","For a patient with a new symptomatic vertebral compression fracture on radiographs and no known malignancy, the following studies are rated **Usually Not Appropriate** as the next imaging study:

- CT spine (area of interest) **with IV contrast**
- CT spine (area of interest) **without and with IV contrast**
- MRI spine (area of interest) **with IV contrast**
- MRI spine (area of interest) **without and with IV contrast**
- CT myelography (spine area of interest)
- FDG-PET/CT (skull base to mid-thigh)

Only noncontrast CT or noncontrast MRI of the spine (area of interest) are usually appropriate as the next study in this scenario."
"In a patient with a new symptomatic vertebral compression fracture on radiographs and no known malignancy, how do MRI spine without IV contrast and CT spine without IV contrast compare in terms of appropriateness as the next imaging study?","For this scenario, both MRI spine area of interest without IV contrast and CT spine area of interest without IV contrast are rated as Usually Appropriate as the next imaging study.","MRI spine without IV contrast is **more appropriate** than CT spine without IV contrast as the next imaging study.

- **MRI without contrast**: Usually rated **“usually appropriate”** for a new, symptomatic vertebral compression fracture with no known malignancy. It best differentiates **acute vs chronic fracture**, evaluates **bone marrow edema**, detects **occult malignancy**, and assesses **spinal cord/nerve root involvement**.

- **CT without contrast**: Typically rated **“may be appropriate”**. It is excellent for **bony detail** and fracture morphology but cannot reliably distinguish **acute vs chronic** fractures or assess marrow/soft tissue as well as MRI.

So, MRI spine without IV contrast is preferred as the next study; CT is secondary or complementary when MRI is contraindicated or unavailable.","Both MRI spine without IV contrast and CT spine without IV contrast are rated as “Usually Appropriate” and are considered equivalent options as the next imaging study. They may be complementary, with MRI better for assessing acuity (bone marrow edema, soft tissues) and CT better for detailed bony anatomy, but either alone is appropriate to obtain next.","For a new symptomatic vertebral compression fracture on radiographs with no known malignancy, **both** of the following are rated **“Usually Appropriate”** as the next imaging study:

- MRI spine (area of interest) **without IV contrast**
- CT spine (area of interest) **without IV contrast**

They are considered **equivalent in appropriateness** as next-step imaging; either can be chosen, and in some cases they may be complementary (MRI better for marrow edema/acuity and soft tissues; CT better for detailed bony anatomy and fracture morphology)."
"You want to minimize unnecessary radiation and contrast exposure when imaging a patient with a new symptomatic vertebral compression fracture seen on radiographs and no known malignancy. Among the listed options, which imaging studies are usually appropriate without requiring IV contrast, and which higher-radiation or contrast-enhanced options are usually not appropriate in this setting?","In this scenario, the usually appropriate options that do not require IV contrast are:
- MRI spine area of interest without IV contrast: Usually Appropriate
- CT spine area of interest without IV contrast: Usually Appropriate

The higher-radiation or contrast-enhanced options that are usually not appropriate are:
- CT spine area of interest with IV contrast: Usually Not Appropriate
- CT spine area of interest without and with IV contrast: Usually Not Appropriate
- MRI spine area of interest with IV contrast: Usually Not Appropriate
- MRI spine area of interest without and with IV contrast: Usually Not Appropriate
- CT myelography spine area of interest: Usually Not Appropriate
- FDG-PET/CT skull base to mid-thigh: Usually Not Appropriate","For a new, symptomatic vertebral compression fracture on radiographs in a patient without known malignancy, and with a goal of minimizing radiation and IV contrast:

**Usually appropriate, no IV contrast (preferred):**
- **MRI of the spine without IV contrast** – best for assessing acuity (edema), canal/cord compromise, and occult pathology.
- **Bone scan (whole body) or SPECT/SPECT-CT** – if you need to confirm acuity or look for additional fractures, though this does involve radiation, it is generally lower-dose than CT of multiple segments and does not require IV iodinated contrast.

**Usually not appropriate (higher radiation and/or IV contrast):**
- **CT of the spine with IV contrast** – adds contrast risk without typical added value for a straightforward osteoporotic compression fracture.
- **CT myelography** – high radiation and invasive intrathecal contrast; reserved for specific indications (e.g., when MRI is contraindicated and detailed canal assessment is essential).
- **MRI of the spine with and without IV contrast** – contrast is usually unnecessary unless there is suspicion of infection, tumor, or other enhancing lesion.
- **PET/CT or contrast-enhanced CT of chest/abdomen/pelvis** – not appropriate in the absence of clinical or imaging suspicion of malignancy.","For a new symptomatic vertebral compression fracture on radiographs with no known malignancy:

Usually appropriate, without IV contrast (and lower radiation where applicable):
- MRI of the spine (area of interest) without IV contrast  
- CT of the spine (area of interest) without IV contrast  
- Bone scan (whole body) – may be appropriate  
- SPECT or SPECT/CT of the spine (area of interest) – may be appropriate  

Usually not appropriate (higher radiation and/or involve IV contrast in this setting):
- CT spine with IV contrast  
- CT spine without and with IV contrast  
- MRI spine with IV contrast  
- MRI spine without and with IV contrast  
- CT myelography  
- FDG-PET/CT (skull base to mid-thigh)","For a patient with a new symptomatic vertebral compression fracture (VCF) on radiographs and no known malignancy, and with a goal to minimize unnecessary radiation and IV contrast exposure:

USUALLY APPROPRIATE STUDIES (no IV contrast)
These are appropriate next imaging studies and do **not** require IV contrast:

- **MRI spine (area of interest) without IV contrast**  
- **CT spine (area of interest) without IV contrast**

MAY BE APPROPRIATE (but involve higher radiation)
These do not use contrast but do involve additional radiation and are generally used selectively (e.g., to look for multiple fractures):

- **Bone scan (whole body)**  
- **SPECT or SPECT/CT spine (area of interest)**

USUALLY NOT APPROPRIATE (higher radiation and/or IV contrast)
These are considered **not appropriate** as the next imaging study in this setting and either use IV contrast and/or add unnecessary radiation:

- **CT spine (area of interest) with IV contrast**  
- **CT spine (area of interest) without and with IV contrast**  
- **MRI spine (area of interest) with IV contrast**  
- **MRI spine (area of interest) without and with IV contrast**  
- **CT myelography (spine area of interest)**  
- **FDG-PET/CT (skull base to mid-thigh)**

So, to minimize unnecessary radiation and contrast, the preferred options are **noncontrast MRI or noncontrast CT of the spine**, with other nuclear medicine or contrast-enhanced studies generally not appropriate as first follow-up imaging in this scenario."
"For a cirrhotic patient bleeding from large high-flow gastric varices with a MELD score of 12, hepatic wedge pressure of 10 mmHg, and a large gastrorenal shunt on MRI, how is TIPS rated for this indication?",TIPS is rated as Usually Appropriate for this scenario.,"For this scenario (large high‑flow gastric varices with a large gastrorenal shunt and relatively low portal pressure), TIPS is generally considered **“not appropriate / rarely appropriate”** as first‑line therapy.

Current practice and appropriateness criteria favor **BRTO (or related obliterative shunt techniques)** over TIPS in patients with:

- Large fundal gastric varices  
- A sizable spontaneous gastrorenal shunt  
- Relatively low portal pressure (wedge 10 mmHg)  
- Preserved liver function (MELD 12)

TIPS is usually reserved for cases where BRTO is not feasible or has failed.",TIPS is rated as “Usually Appropriate” for this indication.,"For this scenario (cirrhotic patient bleeding from large high-flow gastric varices, MELD 12, hepatic wedge pressure 10 mmHg, large gastrorenal shunt on MRI), **TIPS is rated “Usually Appropriate”** as a treatment option.

In the ACR Appropriateness Criteria, this corresponds to Variant 6, where **BRTO, endoscopic management, or TIPS are all rated “Usually Appropriate” and considered equivalent alternatives** (only one would typically be performed)."
"In a cirrhotic patient actively bleeding from large high-flow gastric varices (MELD 12, hepatic wedge pressure 10 mmHg) with a large gastrorenal shunt on MRI, which management options are considered Usually Appropriate according to the criteria?","The procedures rated as Usually Appropriate for this scenario are:
- BRTO
- Endoscopic management
- TIPS","For an actively bleeding, large high‑flow gastric varix with a large gastrorenal shunt, MELD 12, and relatively low portal pressure (wedge 10 mmHg), the options considered **Usually Appropriate** are:

- **Balloon‑occluded retrograde transvenous obliteration (BRTO)**  
- **Plug‑assisted retrograde transvenous obliteration (PARTO)**  
- **Coil‑assisted retrograde transvenous obliteration (CARTO)**  

These retrograde transvenous obliteration techniques are preferred over TIPS in this specific setting.","For this cirrhotic patient (MELD 12, wedge pressure 10 mmHg) with active bleeding from large high-flow gastric varices and a large gastrorenal shunt, the options considered Usually Appropriate are:

- BRTO (balloon-occluded retrograde transvenous obliteration)  
- Endoscopic management  
- TIPS (transjugular intrahepatic portosystemic shunt)","For a cirrhotic patient actively bleeding from large high‑flow gastric varices with MELD 12, hepatic wedge pressure 10 mmHg, and a large gastrorenal shunt on MRI, the ACR Appropriateness Criteria list the following as **Usually Appropriate** management options:

- **BRTO (balloon-occluded retrograde transvenous obliteration)**
- **Endoscopic management**
- **TIPS (transjugular intrahepatic portosystemic shunt)**

These are considered **equivalent alternatives** for this scenario (only one would typically be performed)."
"For a middle-aged patient (35–60 years old) with multiple pulmonary nodules from metastatic cancer where all but one lesion have regressed on current chemotherapy, which management option is specifically rated as Usually Not Appropriate?","For this scenario, Conservative management (do nothing) is rated as Usually Not Appropriate.","For a middle-aged patient (35–60 years) with multiple pulmonary nodules from metastatic cancer where all but one lesion have regressed on current chemotherapy, **surgical resection of the solitary residual pulmonary nodule** is specifically rated as **Usually Not Appropriate**.","For this patient scenario, **conservative management (do nothing)** is specifically rated as **Usually Not Appropriate** (rating 2).","For this scenario (Variant 8 in the ACR Appropriateness Criteria for Radiologic Management of Thoracic Nodules and Masses), the option specifically rated as **Usually Not Appropriate** is:

- **Conservative management (do nothing)** — rating 2 (Usually Not Appropriate)."
"In a middle-aged patient (35–60 years) with known multiple pulmonary nodules from metastatic cancer where all but one lesion have regressed on chemotherapy, how do percutaneous lung biopsy and bronchoscopic biopsy (repeat biopsy) compare in terms of appropriateness?","For this scenario, percutaneous lung biopsy is rated as Usually Appropriate, whereas bronchoscopic biopsy (repeat biopsy) is rated as May Be Appropriate.","In this setting, a **percutaneous (CT‑guided) lung biopsy** is generally more appropriate than a **repeat bronchoscopic biopsy**, assuming the remaining lesion is peripherally located and reachable percutaneously.

**Rationale:**

- **Percutaneous lung biopsy**
  - Best for **peripheral or subpleural nodules**, especially solitary residual lesions.
  - Higher diagnostic yield for small, peripheral metastases.
  - Allows targeted sampling of the specific lesion that failed to regress, which is important to:
    - Confirm persistent metastasis vs. benign/inflammatory change.
    - Exclude a second primary lung cancer.
    - Obtain tissue for updated molecular testing if needed.

- **Bronchoscopic biopsy**
  - Best for **central, endobronchial, or peribronchial lesions**.
  - Yield is lower for small, peripheral nodules unless advanced techniques (EBUS, navigational bronchoscopy) are available and the lesion is adjacent to an airway.
  - A “repeat” bronchoscopic biopsy of previously sampled disease is less useful if the target lesion is new/different or peripherally located.

**Conclusion:**  
For a single residual pulmonary nodule after regression of other metastatic nodules, **CT‑guided percutaneous biopsy is usually preferred**, unless the lesion is clearly central and bronchoscopically accessible, in which case advanced bronchoscopic techniques may be considered.","For this scenario (Variant 8):

- **Percutaneous lung biopsy** is rated higher (7 – usually appropriate). It is preferred when the nonresponding lesion is accessible percutaneously, because sampling is important for mutational testing and to distinguish mutation-driven resistance versus a second primary, especially if results will change therapy.

- **Bronchoscopic biopsy (repeat biopsy)** is slightly less favored (rating 6 – may be appropriate). It is appropriate only if the lesion is adjacent to an airway and amenable to traditional, navigational, or image-guided (e.g., EBUS) bronchoscopic techniques.

So, percutaneous biopsy is generally more appropriate overall, with bronchoscopic biopsy reserved for lesions that are well-suited to airway-based access.","In this scenario (ACR Variant 8 – middle‑aged patient with multiple metastatic pulmonary nodules where all but one have regressed on chemotherapy):

- **Percutaneous lung biopsy** is rated **7 (Usually Appropriate)**.
- **Bronchoscopic biopsy (repeat biopsy)** is rated **6 (May Be Appropriate)**.

So percutaneous lung biopsy is considered more appropriate (Usually Appropriate), while bronchoscopic biopsy is one step lower (May Be Appropriate) and is suggested mainly if the lesion is adjacent to an airway and technically amenable to bronchoscopic sampling."
"You are trying to minimize radiation exposure in a middle-aged patient with multiple pulmonary nodules from metastatic cancer, where all but one lesion have regressed on chemotherapy. Among the listed options, which management strategies could be considered that do not inherently require ionizing radiation–based imaging for the intervention itself?","In this scenario, the options that could be considered and do not inherently require ionizing radiation–based imaging for the intervention itself are:
- Surgical lung biopsy/resection (May Be Appropriate)
- Follow-up imaging only (May Be Appropriate)
- Conservative management (do nothing) (Usually Not Appropriate)

Note: FDG-PET/CT uses ionizing radiation, and percutaneous lung biopsy and bronchoscopic biopsy typically rely on imaging guidance or fluoroscopy that involve ionizing radiation.","Management strategies that could be considered, because the intervention itself does not inherently require ionizing radiation–based imaging, include:

- **Video-assisted thoracoscopic surgery (VATS) wedge resection** of the persistent nodule (using direct/thoracoscopic visualization rather than fluoroscopic guidance).  
- **Open thoracotomy with wedge or segmental resection** of the lesion.  
- **Bronchoscopic approaches** (e.g., navigational bronchoscopy, endobronchial biopsy) when they rely on endoscopic visualization and non–ionizing adjuncts (e.g., electromagnetic navigation, ultrasound) rather than fluoroscopy.  

In contrast, CT-guided percutaneous biopsy or ablation and fluoroscopy-guided procedures inherently require ionizing radiation.","From the listed options for this scenario (Variant 8), the strategies that do not inherently require ionizing radiation–based imaging for the intervention itself are:

- Bronchoscopic biopsy (including image-guided TBNA/EBUS, which uses ultrasound rather than ionizing radiation)
- Surgical lung biopsy/resection
- Conservative management (do nothing)

“Follow-up imaging only,” percutaneous lung biopsy, and FDG-PET/CT all inherently rely on ionizing radiation–based imaging.","For this scenario (middle-aged patient with multiple pulmonary nodules from metastatic cancer where all but one has regressed on chemotherapy), the ACR Variant 8 table lists these management options:

- Percutaneous lung biopsy
- Bronchoscopic biopsy (repeat biopsy)
- FDG-PET/CT whole body
- Surgical lung biopsy/resection
- Follow-up imaging only
- Conservative management (do nothing)

If you want to **minimize radiation exposure** and focus on strategies that **do not inherently require ionizing radiation–based imaging for the intervention itself**, the options that qualify are:

1. **Bronchoscopic biopsy (repeat biopsy)**  
   - The procedure itself is endoscopic and does not intrinsically require ionizing radiation.  
   - Image guidance (e.g., EBUS or navigational bronchoscopy) can be performed without ionizing radiation, though in some centers fluoroscopy may still be used.

2. **Surgical lung biopsy/resection**  
   - The surgical procedure itself does not inherently require ionizing radiation.  
   - Preoperative imaging is typically CT-based, but the intervention per se is non–radiation based.

3. **Conservative management (do nothing)**  
   - Involves no intervention and no additional imaging, therefore no further radiation exposure.

The other options (percutaneous lung biopsy, FDG-PET/CT, and follow-up imaging only) inherently depend on CT/PET or other radiographic imaging and therefore involve ionizing radiation as part of their core use."
